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Dedication  
Abstract: A versatile synthesis of azidolactones through azidation 
and cyclization of carboxylic acids onto alkenes has been 
developed. Based on either photoredox or palladium catalysis, 
(1,1) and (1,2) azido lactones can be selectively synthesized. The 
choice of catalyst and benziodoxol(on)e reagent serving as azide 
source was essential to initiate either a radical or Lewis Acid 
mediated process with divergent outcome. These transformations 
were carried out under mild conditions using a low catalyst 
loading and gave access to a large scope of azido lactones.  
Amino lactones have found widespread applications in natural 
product synthesis and in medicinal chemistry.[1] Furthermore, they 
serve as versatile starting materials for accessing other important 
building blocks, such as amino alcohols.[2] As non-basic precursors 
of amines, azides are highly useful synthetic intermediates on the 
way to nitrogen-rich compounds. They can also be transformed 
easily into various other nitrogen-containing functional groups.[3] 
Therefore, azidolactones are versatile and convenient precursors of 
both amino lactones and alcohols. Nevertheless, the preparation of 
azidolactones is usually based on multi-step protocols and lacks 
efficiency. The installation of the azido group commonly proceeds 
through substitution reactions on pre-functionalized substrates, 
such as halides.[4] Very recently, a copper catalyzed 
enantioselective radical azidocarboxylation of alkenes was 
developed by Buchwald and co-workers using phenyliodine 
diacetate (PIDA) and TMSN3 as azide source, giving access to 
(1,2)-azidolactones 2 (Scheme 1, A).[5] However, this method is 
based on the in situ formation of highly reactive and potentially 
explosive hypervalent iodine reagents for the generation of the 
needed azide radical. Furthermore, this approach is limited to the 
synthesis of (1,2)-azidolactones: access to the (1,1) regioisomers, if 
possible from the same starting materials, would be highly 
attractive to extend the range of accessible azidolactones. (1,1)-
Azidolactones are a largely unexplored class of compounds, which 
have been reported only rarely in the literature.[6]  
In recent years, benziodoxol(on)es, a class of stable cyclic 
hypervalent iodine reagents, have emerged as privileged reagents 
for the transfer of functional groups via non-conventional 
reactivity.[7] AzidoBenziodoXolone (ABX, 3a) and 
AzidoDimethyl-BenziodoXole (ADBX, 3b) (Scheme 1) have been 
first described by Zhdankin and co-workers[8] and are stable solids 
decomposing at temperature higher than 100 °C.[9] They have been 
used as azide transfer reagents in presence of metal catalysts, 
relying either on radical-based[8,10] or Lewis-acid mediated 
pathways.[11] In particular, the azidation of styrene-type double 
bonds has recently attracted much interest and ABX (3a) and 
ADBX (3b) have emerged as good sources of azide radicals under 
reductive conditions.[10a,h,j,l] In 2015, Greaney and co-workers 
reported the photoredox-catalyzed nucleoazidation of styrenes 
using the Sauvage/McMillin catalyst Cu(dap)2Cl
[12] and ABX 
reagent 3a, resulting in particularly mild reaction conditions.[10h] 
On the other hand, the azidation of ketoesters and silyl enol ethers 
has been successful in the presence of Lewis acids.[11] 
Nevertheless, to the best of our knowledge, 
azidobenziodoxol(on)es have never been used in the synthesis of 
azidolactones. 
 
Scheme 1. Synthesis of Azidolactones from Alkenes. 
Herein, we report the first synthesis of azidolactones based on the 
use of azidobenziodoxol(on)es (Scheme 1, B). The diverging 
behavior of ABX (3a) and ADBX (3b) in presence of metal 
catalysts led to either a radical-based or Lewis Acid mediated 
pathway, allowing the selective formation of (1,2)- or (1,1)- 
azidolactones 2 and 4 starting from styrene derivatives. The 
former was achieved under mild photoredox conditions using 
visible light irradiation and only 0.5 mol% Cu(dap)2Cl as catalyst, 
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whereas the later was realized by Lewis acid activation of the 
hypervalent iodine reagent, involving an aryl migration step. 
Furthermore, the synthesis of (1,2)-azidolactones starting from 
olefins without arene substituent was possible using Lewis acid 
activation. 
Based on the impressive work of Greaney and co-workers,[10h]  we 
started our investigations with the photoredox catalysis strategy for 
the formation of (1,2)-azidolactone 2 from unsaturated carboxylic 
acid 1 (Scheme 2). Only ABX (3a) was successful in this 
transformation. Upon a fine adjustment of the reaction 
conditions,[13] the desired azidolactone 2a could be isolated in 81% 
yield with 0.5 mol% of the photoredox catalyst under blue LED 
irradiation. Interestingly, while the reaction also worked in the 
absence of light, conversion to product 2a dropped to 20%. This 
indicated that a radical chain process was possible, but less 
efficient. Using the combination of PIDA and TMSN3 for azide 
radical formation,[5] only traces of 2a were detected.   
With this simple protocol for azidation in hands, we investigated 
the scope of the reaction (Scheme 2). A broad series of unsaturated 
carboxylic acids 1 containing substituted aryl groups was 
converted into the corresponding azidolactones 2 in good to 
excellent yields. Electron rich (2b, 2c) as well as halogen-
substituted arenes (2d-f) were well tolerated. A more rigid benzene 
backbone led to excellent yields of (1,2)-azido-phthalide 
derivatives 2g-i. Dimethyl-substituted lactone 2j was also obtained 
in 90% yield. A thiophene heterocycle was compatible with the 
reaction conditions (2k, 87%). An aromatic ring bearing a group in 
the ortho position was also tolerated (2l, 71%). Tricyclic (1,2)-
azido-γ-butyrolactone 2m was obtained in 65% yield. When enoic 
acid 1n containing a 1,3-enyne motif was used, azidation product 
2n was formed in 47% yield. Importantly, (1,2)-azido-δ-lactones 
could be also obtained under the same reaction conditions, 
although lower yields were observed (product 2o-q). Scale up of 
the reaction demonstrated that even lower catalyst loadings were 
possible: 1.0 g of 2e was isolated in 82% yield using only 0.05 
mol% catalyst.  
 
Scheme 2. Scope of the (1,2)-azidolactonization.  
In contrast, when ADBX (3b) was used instead of ABX (3a) under 
the optimized photoredox conditions, only traces of (1,2)-azido-γ-
butyrolactones 2a were observed. The major product was 4-oxo-5-
phenylpentanoic acid (5), which was isolated in 40% yield. 
(Equation 1) We speculated that 5 could originate from the 
hydrolysis of a (1,1)-azidolactone 4a formed from reaction of the 
hypervalent iodine reagent with the double bond followed by 1,2-
phenyl migration. In fact, such rearrangements have been observed 
for oxygenation or fluorination,[14] but are unprecedented for 
azidation with benziodoxole reagents. In this case, the copper 
catalyst probably acted as a Lewis acid to activate ADBX (3b) and 
not as a redox active catalyst able to generate the azide radical after 
a SET event. 
 
Equation 1. Reaction of 1a with ADBX (3b). 
In fact, in presence of several Lewis acid catalysts such as 
Zn(OTf)2, In(OTf)3 and Sn(OTf)2, (1,1)-azidolactone 4a could be 
isolated as the major product.[13] Pd(hfacac)2 (2 mol%) was 
identified as the best catalyst for this transformation leading to 4 in 
75% yield by NMR. Sn(OTf)2 provided similar results, but with 
lower reproducibility. The low catalyst loading is noteworthy, as 
most reported oxidative rearrangements required stoichiometric 
amounts of Lewis or Brønsted acids.[14] Although 4a was sensitive 
to hydrolysis, it was still possible to purify it by column 
chromatography (52% pure 4a isolated).  
 
Scheme 3. Scope of (1,1)-azidolactonization of 1. (isolated yield 
given, NMR yield in brackets). a) Isolated as a mixture with 2-(2-
iodophenyl)propan-2-ol. 
The reaction worked efficiently in the presence of halogen and 
methyl substituents on the aromatic ring, affording products 4b-f in 
55-80% yield. A thiophenyl group was also able to migrate, 
affording 4g in 52% isolated yield. A geminal dimethyl substituted 
substrate 1h gave the more stable azido lactone 4h in 77% isolated 
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yield. Finally, (1,1)-azido-phthalide derivatives 4i, 4j, 4k were also 
generated in high yields.  
Due to the high sensitivity of the obtained (1,1)-azidolactones, the 
direct modification of the crude products was then investigated 
(Scheme 4). Copper catalyzed cycloaddition starting from 4k and 
phenylacetylene gave triazole 6 as a stable crystalline solid in 65% 
yield over two steps starting from the olefin. Hydrogenation of the 
crude reaction mixture containing 4a in EtOAc, using 5 mol% of 
Pd/C, afforded ketone 5 in 75% yield over two steps.[15] The γ-
ketoester could be selectively generated through the hydrogenation 
of the crude material of 4a in methanol in 70% yield over two 
steps. When using 10 mol% of Pt black as catalyst with (1,1)-
azido-γ-butyrolactone 4d in the presence of Boc2O, the N-Boc 
protected Gamma AminoButyric Acid (GABA) derivative 8 was 
isolated in 48% yield. The GABA motif is commonly found in 
many bioactive compounds and is an important target in synthetic 
chemistry.[16] In the case of (1,1)-azido-phthalide derivative 4k, 
only azide reduction was observed under Pt/C catalysis and the 
(1,1)-amino-phthalide 9 was isolated in 80% yield. These 
successful transformations demonstrated the potential of (1,1)-
azidolactones as useful building blocks. 
 
Scheme 4. Product modifications. *Isolated yields over two steps 
from 1. Reaction conditions: a) CuI (10 mol%), Et3N (3.0 equiv.), 
phenylacetylene (2.0 equiv.), THF, 25°C; b) H2, Pd/C (5 mol%), 
EtOAc, 25 °C; c) H2, Pd/C (2.5 mol%), MeOH, 25 °C; d) H2, Pt black 
(10 mol%), Boc2O (2.0 equiv.), THF, 25 °C.  
In order to investigate the generality of the 1,2-shift, we then 
replaced the aryl substituent by a simple alkyl group (Scheme 5). 
No (1,1)-azidolactone was obtained with a benzyl group: only 
traces of (1,2)-azidolactonization product 2r could be observed. 
1,2-Azidolactone 2s could be obtained in 40% with a phenyl group 
in position to the alkene. Interestingly, compounds 2s is not 
formed under photoredox conditions, as an aryl group on the 
alkene is required for oxidation of the carbon centered radical 
intermediate. Better yields were obtained with more rigid 
substrates derived from benzoic acid (products 2g and 2t-v). -
lactone 2g can be synthesized in better yield under photoredox 
conditions, but -lactone 2t-v can be accessed only with Lewis acid 
catalysis, showing that the two methods are highly complementary.  
Based on the precedence in literature on radical and Lewis acid 
pathways with hypervalent iodine reagents,[10,14] a speculative 
mechanism can be proposed for the developed transformations 
(Scheme 6). The better results obtained with ABX (3a) under 
photoredox conditions could be due to its expected stronger 
oxidant character when compared to ADBX (3b).[17] In contrast, 
the Lewis acid catalytic cycle would be initiated by the activation 
of ADBX (1b).[18] The resulting more electrophilic complex I will 
react with alkene 1 to give iodocyclopropylium cation II.  
 
Scheme 5. Lewis acid catalyzed synthesis of (1,2)-azidolactones. a) 
20 h of reaction. b) 10 mol% of Pd(hfacac)2 were used. 
A proton transfer can also be expected from the carboxylic acid to 
the more basic alkoxide, a key step to promote catalyst turnover 
only possible with 3b. Ring opening through the attack of the 
carboxylic acid delivers then the highly electrophilic intermediate 
III. In case of aliphatic substituents, direct substitution with the 
azide would occur, leading to (1,2)-azidolactones 2. In case of aryl 
substituents, 1,2-migration via a phenonium ion or a non-classical 
carbocation IV is faster and gives product 4a. Further works will 
be needed to support this speculative mechanism. 
 
Scheme 6. Speculative reaction mechanism. 
In conclusion, we have reported a general and versatile 
synthesis of azidolactones starting from alkene-containing 
carboxylic acids. A large range of (1,1) and (1,2)-azidolactones 
were obtained selectively in high yields and with broad functional 
group tolerance. The fine modulation of the reactivity possible for 
benziodoxolone reagents was key to enable either a photoredox or 
a Lewis acid pathway to access (1,1)- and (1,2)-azidolactones 
respectively. These results further establish the exceptional 
potential of cyclic hypervalent iodine reagents for group transfer 
reactions and will allow a broader use of azidolactones as useful 
building blocks in synthetic and medicinal chemistry. 
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1. General Methods 
All reactions were carried out in oven dried glassware under an atmosphere of nitrogen, unless 
stated otherwise. For quantitative flash chromatography technical grade solvents were used. For 
flash chromatography for analysis, HPLC grade solvents from Sigma-Aldrich were used. THF, 
Et2O, CH3CN, toluene, hexane and CH2Cl2 were dried by passage over activated alumina under 
nitrogen atmosphere (H2O content < 10 ppm, Karl-Fischer titration). NEt3 and pyridine were 
distilled under nitrogen from KOH. The solvents were degassed by Freeze-Pump-Thaw method 
when mentioned. All chemicals were purchased from Acros, Aldrich, Fluka, VWR, Aplichem or 
Merck and used as such unless stated otherwise. Chromatographic purification was performed as 
flash chromatography using Macherey-Nagel silica 40-63, 60 Å, using the solvents indicated as 
eluent with 0.1-0.5 bar pressure. TLC was performed on Merck silica gel 60 F254 TLC glass 
plates or aluminium plates and visualized with UV light, permanganate stain, CAN stain or 
Anisaldehyde stain or Seebach stain (Phosphomolybdid acid, Ce(SO4)2, H2SO4, water). Melting 
points were measured on a Büchi B-540 melting point apparatus using open glass capillaries, the 
data is uncorrected. 
1
H-NMR spectra were recorded on a Brucker DPX-400 400 MHz 
spectrometer in chloroform-d, DMSO-d6 or CD3OD, all signals are reported in ppm with the 
internal chloroform signal at 7.26 ppm, the internal DMSO signal at 2.50 ppm or the internal 
methanol signal at 3.30 ppm as standard. The data is being reported as (s =  singlet, d =  doublet, 
t =  triplet, q =  quadruplet, qi =  quintet, m =  multiplet or unresolved, br =  broad signal, app =  
apparent, coupling constant(s) in Hz, integration, interpretation).
13
C-NMR spectra were recorded 
with 
1
H-decoupling on a Brucker DPX-400 100 MHz spectrometer in chloroform-d, DMSO-d6 or 
CD3OD, all signals are reported in ppm with the internal chloroform signal at 77.0 ppm, the 
internal DMSO signal at 39.5 ppm or the internal methanol signal at 49.0 ppm as standard. 
Infrared spectra were recorded on a JASCO FT-IR B4100 spectrophotometer with an ATR 
PRO410-S and a ZnSe prisma and are reported as cm
-1
 (w = weak, m =  medium, s =  strong, br 
=  broad). High resolution mass spectrometric measurements were performed by the mass 
spectrometry service of ISIC at the EPFL on a MICROMASS (ESI) Q-TOF Ultima API. High 
resolution mass spectrometric measurements were performed by the mass spectrometry service of 
ISIC at the EPFL on a MICROMASS (ESI) Q-TOF Ultima API. Reactions were performed in 
test tubes (1.0 to 10 mL) which were hold using a rack for test tubes placed at the center of a 
crystallization flask, the latter was continuously flushed with air in order to keep the temperature 
as constant as possible. On this flask were attached the blue LEDs (RUBAN LED 5MÈTRES - 
60LED/M - 3528 BLEU - IP65 with Transformateur pour Ruban LED 24W/2A/12V, bought 
directly on RubanLED.com). The distance between the LEDs and the test tubes was 
approximatively 3 cm. Temperature ranged between 25 and 30 °C, and long irradiation resulted 
in temperature increasing up to 34 °C during overnight reactions. Cu[dap]2Cl complex was 
purchased from Sigma-Aldrich and used as received. 
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2. Synthesis of Hypervalent Iodine Reagents 
 Synthesis of 1-azido-1,2-benziodoxole-3-(1H)-one (3a) a.
1-Hydroxy-1,2-benziodoxol-3-(1H)-one (11) 
 
NaIO4 (7.24 g, 33.8 mmol, 1.00 equiv) and 2-iodo benzoic acid (10) (8.00 g, 32.2 mmol, 1.00 
equiv) were suspended in 30% (v:v) aq AcOH (48 mL) under air. The mixture was vigorously 
stirred and refluxed for 4 h. the reaction mixture was then diluted with cold water (180 mL) and 
allowed to cool to room temperature, protecting it from light. The mixture is then filtered and 
further washed with ice water and cold acetone, air dried in the dark overnight to give the pure 
compound 11 (8.14 g, 30.4 mmol, 94% ) as a colorless solid. 
1
H NMR (400 MHz, (CD3)2SO) 
8.02 (dd, J = 7.7, 1.4 Hz, 1H, ArH), 7.97 (m, 1H, ArH), 7.85 (dd, J = 8.2, 0.7 Hz, 1H, ArH), 7.71 
(td, J = 7.6, 1.2 Hz, 1H, ArH). 
13
C NMR (100 MHz, (CD3)2SO) 167.7, 134.5, 131.5, 131.1, 
130.4, 126.3, 120.4. IR 3083 (w), 3060 (w), 2867 (w), 2402 (w), 1601 (m), 1585 (m), 1564 (m), 
1440 (m), 1338 (s), 1302 (m), 1148 (m), 1018 (w), 834 (m), 798 (w), 740 (s), 694 (s), 674 (m), 
649 (m). NMR data correspond to the reported values.
 [1] 
1-Acetoxy-1,2-benziodoxol-3-(1H)-one (12) 
 
Following a reported procedure,
[2] 
 compound 11 (3.00 g, 11.3 mmol, 1.00 equiv) was heated in 
Ac2O (10 mL) to reflux until the solution turned clear (without suspension). The mixture was 
then left to cool down and white crystals started to form. The crystallization was continued at -18 
°C. The crystal were then collected and dried overnight under high vacuum to give compound 12 
(3.06 g, 10.0 mmol, 86%). 
1
H NMR (400 MHz, CDCl3) δ 8.25 (dd, J = 7.6, 1.4 Hz, 1H, ArH), 
8.00 (dd, J = 8.3, 0.5 Hz, 1H, ArH), 7.92 (dt, J = 7.0, 1.7 Hz, 1H, ArH), 7.71 (td, J = 7.6, 0.9 Hz, 
1H, ArH), 2.25 (s, 3H, COCH3). NMR data correspond to the reported values. 
[2]  
1-Azido-1,2-benziodoxole-3-(1H)-one (3a) 
 
Caution: reaction carried out behind a safety shield! Following a reported procedure,
[3]
 
compound 12 (1.00 g, 3.28 mmol, 1.00 equiv) was stirred in dry DCM (3 m) then TMSN3 (0.66 
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mL, 4.9 mmol, 1.5 equiv) was cautiously added. A catalytic amount of TMSOTf (3 µL, 0.02 
mmol, 0.005 equiv) was added last to the mixture which was then stirred for 30 minutes. The 
reaction mixture was then died in vacuo to give a yellow precipitate, which was washed a few 
times with hexanes to give compound 3a (0.70 g, 2.4 mmol, 74%) as a pure pale yellow crystal. 
1
H NMR (400 MHz, CDCl3:CH3CN; 10:1) δ 8.17 (dd, J = 7.5, 1.3 Hz, 1H, ArH), 7.93 (m, 2H, 
ArH), 7.70 (m, 1H, ArH). 
13
C NMR (101 MHz, CDCl3:CH3CN; 10:1) δ 166.2, 134.8, 131.8, 
130.4, 125.4, 116.6, 115.4. IR 2049 (s), 1639 (s), 1565 (m), 1440 (w), 1347 (w), 1295 (m).The 
analysis data for the characterization of 3a correspond to the ones reported in the literature.
[3]
 
Caution: Although compound 3a is relatively stable, in our lab laboratory, it detonated in two 
instances. Diffrential scanning calorimetry analysis confirmed its explosive character.
[4]
 
 Synthesis of 1-azido-3,3-dimethyl-3-(1H)-1,2-benziodoxole (3b) b.
1-Chloro-1,3-dihydro-3,3-dimethyl-1,2-benziodoxole (14) 
 
Following a reported procedure,
[5]
 methyl 2-iodobenzoate 13 (12 mL, 76 mmol) was dissolved 
under N2 atmosphere in dry diethyl ether (400 mL) and then the solution was cooled down at 0 
°C with an ice bath. Methylmagnesium bromide (56.0 mL, 168 mmol, 2.20 equiv) was added 
dropwise and the reaction was stirred for 30 min at 0 °C. The reaction mixture was then allowed 
to warm to room temperature and it was further stirred for 16 h. The reaction was quenched with 
NH4Cl in an iced bath. The organic layer was separated and extracted with Et2O (3 x 100 mL), 
water (2 x 200 mL), brine (1 x 100 mL) and the combined organic layers were dried over MgSO4. 
The solvent was removed in vacuum.  The crude mixture (9.1 g, 33.0 mmol, 1.0 equiv.)  was 
dissolved in anhydrous ACN (65mL) and the mixture as stirred and heated at 75 °C. In an 
additional funnel was dissolved the 1,3,5-trichloro-1,3,5-triazinane-2,4,6-trione (2.56 g, 11.0 
mmol, 0.33 equiv.) in anhydrous ACN (50 mL). The resulting solution was added to the stirred 
solution of 2-(2-iodophenyl)propan-2-ol within 5 min. The reaction was refluxed 5 min and 
filtered on a pad of Celite and the cake was washed with hot ACN (3 x 15 mL). The resulting 
filtrate was concentrated un vacuum and the solid was washed with pentane (2 x 20 mL) and with 
a minimum of cold acetone to give the compound 14 (7.11 g, 23.9 mmol, 73 % yield). 
1
H NMR 
(400 MHz, CDCl3) δ 8.03 (dd, J = 8.1, 1.1 Hz, 1H, ArH), 7.55 (m, 2H, ArH), 7.17 (dd, J = 7.3, 
1.7 Hz, 1H, ArH), 1.55 (s, 6 H, (CH3)2).
 13
C NMR (101 MHz, CDCl3) δ 149.5, 131.0, 130.5, 
128.4, 126.1, 114.7, 85.2, 29.2. IR 3729 (w), 3626 (w), 2972 (w), 2924 (w), 2362 (w), 2055 (w), 
2018 (w), 1742 (w), 1564 (w), 1464 (w), 1439 (w), 1379 (w), 1378 (w), 1366 (w), 1277 (w), 
1276 (w), 1256 (w), 1181 (w), 1154 (m), 1112 (w), 1048 (w), 1003 (w), 982 (w), 943 (m), 866 
(m), 808 (w), 790 (w), 789 (w), 762 (s), 745 (w), 724 (w), 718 (w). NMR data correspond to the 
reported values.
[5]
 
 
1-Acetoxy-1,3-dihydro-3,3-dimethyl-1,2-benziodoxole (15) 
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Following a reported procedure[5] 1-Chloro-1,3-dihydro-3,3-dimethyl-1,2-benziodoxole 14 (2.60 
g, 8.77 mmol) was dissolved in dry acetonitrile (25 mL) under N2 atmosphere. The reaction flask 
was covered with aluminum foils and protected from light. Silver acetate (1.46 g, 8.77 mmol, 
1.00 equiv) was then added in one portion. The reaction mixture was stirred in the dark at room 
temperature for 16 h. Filtration over a Celite plug and evaporation of the solvent yielded 
compound 15 (2.6 g, 8.8 mmol, 93%) as a light brownish solid. 1H NMR (400 MHz, CDCl3) δ 
7.79 (dd, J = 8.0, 1.3 Hz, 1H, ArH), 7.47 (m, 2H, ArH), 7.18 (dd, J = 7.2, 1.7 Hz, 1H, ArH), 2.11 
(s, 3H, COCH3), 1.52 (s, 6H, (CH3)2).
 13C NMR (101 MHz, CDCl3) δ 177.4, 149.4, 130.4, 130.0, 
129.9, 126.2, 115.7, 84.6, 29.2, 21.5. IR 3099 (w), 3057 (w), 2975 (w), 2930 (w), 2930 (w), 2865 
(w), 1740 (w), 1640 (s), 1588 (w), 1566 (w), 1462 (w), 1438 (m), 1363 (s), 1294 (s), 1259 (m), 
1158 (m), 1114 (w), 1047 (w), 1033 (w), 1009 (w), 949 (m), 926 (w), 866 (w), 761 (s), 723 (w). 
NMR data correspond to the reported values.[5] 
 
1-Azido-3,3-dimethyl-3-(1H)-1,2-benziodoxole (3b) 
 
Caution: This reaction should be carried out behind a safety shield! Following a reported 
procedure2 1-Acetoxy-1,3-dihydro-3,3-dimethyl-1,2-benziodoxole 15 (2.30 g, 7.18 mmol) was 
dissolved in dry CH2Cl2 (36 mL) under N2 atmosphere. The reaction was placed in an iced bath 
and trimethylsilylazide (0.954 mL, 7.18 mmol, 1.00 equiv) was added via syringe, followed by 
TMSOTf (0.065 mL, 0.36 mmol, 0.050 equiv). The reaction was stirred for 15 min then the ice 
bath was removed and the stirring was continued for 1 h. The solvent was evaporated and the 
solid obtained was washed with n-hexane (2 x 30 mL, HLPC purity) to afford 3b as a yellow 
crystalline solid (2.10 g, 7.18 mmol, 96%). 1H NMR (400 MHz, CDCl3) δ 7.77 (d, J = 8.0 Hz, 
1H, ArH), 7.55 (m, 2H, ArH), 7.23 (d, J = 7.2 Hz, 1H, ArH), 1.53 (s, 6H, (CH3)2). 
13C NMR (101 
MHz, CDCl3) δ 149.2, 130.9, 130.4, 127.8, 126.8, 114.0, 83.2, 29.6. IR 3254 (w), 3085 (w), 3051 
(w), 2976 (w), 2928 (w), 2860 (w), 2486 (w), 2026 (s), 1918 (w), 1764 (w), 1697 (w), 1651 (w), 
1589 (w), 1562 (w), 1462 (m), 1428 (m), 1380 (w), 1364 (w), 1312 (w), 1273 (w), 1248 (s), 1182 
(w), 1151 (m), 1111 (m), 1031 (w), 1004 (w), 943 (m), 910 (m), 880 (w), 863 (m). NMR data 
correspond to the reported values. [5] 
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3. Synthesis of starting materials  
 General procedure for synthesis of ketone precursors using Friedel-a.
Craft reaction 
 
A 100-mL, three-necked, round-bottomed flask is charged with powdered dihydrofuran-2,5-dione 
17 (1.0 equiv.) and arene 16 (1.0 equiv.) under dry nitrogen. The resulting white mixture was 
cooled to 0 °C before anhydrous aluminum trichloride (1.2 equiv.) was added in one portion. The 
reaction mixture was stirred over a period of 4 h before allowing it to warm to room temperature 
for 16 h. The reaction was poured in ice and 10 mL of concentrated hydrochloric acid was added 
under stirring at 0 °C. The organic layer was separated and the aqueous layer was extracted with 
DCM twice. The combined organic layers were washed with water, dried over MgSO4 and 
concentrated. Product was engaged in the next step without further purification. 
 
4-(4-Methoxyphenyl)-4-oxobutanoic acid (18a) 
 
According to the general procedure, starting from dihydrofuran-2,5-dione 17 (2.75 g, 27.5 mmol, 
1.0 equiv.), aluminum trichloride (4.41 g, 33.0 mmol, 1.2 equiv.) and anisole 16a (3.00 mL, 27.5 
mmol), the product was obtained as a white solid (4.67 g, 22.4 mmol, 82 % yield). 
1
H NMR (400 
MHz, CDCl3) δ 7.96 (d, J = 8.8 Hz, 2H, ArH), 6.94 (d, J = 8.8 Hz, 2H, ArH), 3.87 (s, 3H, Me), 
3.27 (t, J = 6.6 Hz, 2H, CH2CH2CO2H), 2.80 (t, J = 6.6 Hz, 2H, CH2CH2CO2H). NMR data 
correspond to the reported values.
[6]
 
 
4-(4-Fluorophenyl)-4-oxobutanoic acid (18b) 
 
According to the general procedure, starting from dihydrofuran-2,5-dione 17 (2.75 g, 27.5 mmol, 
1.0 equiv.), aluminum trichloride (4.41 g, 33.0 mmol, 1.2 equiv.) and fluorobenzene 16b (3.89 
mL, 41.2 mmol 1.0 equiv.), the product was obtained as a white solid (4.12 g, 20.9 mmol, 76 % 
yield). 
1
H NMR (400 MHz, CDCl3) δ 8.01 (dd, J = 8.6, 5.4 Hz, 2H, ArH), 7.14 (t, J = 8.5 Hz, 
2H, ArH), 3.28 (t, J = 6.5 Hz, 2H, CH2CH2CO2H), 2.81 (t, J = 6.5 Hz, 2H, CH2CH2CO2H). NMR 
data correspond to the reported values.
[6]
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4-(4-Bromophenyl)-4-oxobutanoic acid (18c) 
 
According to the general procedure, starting from dihydrofuran-2,5-dione 17 (2.85 g, 28.5 mmol, 
1.0 equiv.), aluminum trichloride (4.56 g, 34.2 mmol, 1.2 equiv.) and bromobenzene 16c (3.05 
mL, 28.5 mmol, 1.0 equiv.), the product was obtained as a white solid (4.80 g, 18.7 mmol, 65 % 
yield). 
1
H NMR (400 MHz, CDCl3) δ 7.84 (d, J = 8.3 Hz, 2H, ArH), 7.61 (d, J = 8.6 Hz, 2H, 
ArH), 3.27 (t, J = 6.5 Hz, 2H, CH2CH2CO2H), 2.81 (t, J = 6.5 Hz, 2H, CH2CH2CO2H). NMR 
data correspond to the reported values.
[6]
 
 
4-(4-Chlorophenyl)-4-oxobutanoic acid (18d) 
  
 
According to the general procedure, starting from dihydrofuran-2,5-dione 17 (2.93 g, 29.3 mmol, 
1.0 equiv.), aluminum trichloride (4.69 g, 35.2 mmol, 1.2 equiv.) and chlorobenzene 16d (3.00 
mL, 29.3 mmol, 1.0 equiv.), the product was obtained as a white solid (4.75 g, 22.3 mmol, 76 % 
yield). 
1
H NMR (400 MHz, CDCl3) δ 7.92 (d, J = 8.3 Hz, 2H, ArH), 7.44 (d, J = 8.3 Hz, 2H, 
ArH), 3.28 (t, J = 6.5 Hz, 2H, CH2CH2CO2H), 2.81 (t, J = 6.5 Hz, 2H, CH2CH2CO2H). NMR 
data correspond to the reported values. 
[6]
 
 
4-(2,5-Dimethylphenyl)-4-oxobutanoic acid (18e) 
 
According to the general procedure, starting from dihydrofuran-2,5-dione 17 (2.45 g, 24.5 mmol, 
1.0 equiv.), aluminum trichloride (3.92 g, 29.4 mmol, 1.2 equiv.) and p-xylene 16e (3.00 mL, 
24.5 mmol, 1.0 equiv.), the product was obtained as a beige solid (2.7 g, 13 mmol, 53 % yield). 
1
H NMR (400 MHz, CDCl3) δ 7.50 (d, J = 1.8 Hz, 1H, ArH), 7.19 (dd, J = 7.9, 1.7 Hz, 1H, 
ArH), 7.13 (d, J = 7.8 Hz, 1H, ArH), 3.22 (t, J = 6.5 Hz, 2H, CH2CH2CO2H), 2.79 (t, J = 6.5 Hz, 
2H, CH2CH2CO2H), 2.45 (s, 3H, Me), 2.36 (s, 3H, Me). NMR data correspond to the reported 
values.
[6]
 
 
3,3-Dimethyl-5-oxo-5-phenylpentanoic acid (20) 
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A 100-mL, three-necked, round-bottomed flask was charged with powdered 3,3-Dimethylglutaric 
anhydride 19 (1.50 g, 10.5 mmol, 1.0 equiv.) and benzene 16f (3.00 mL, 33.4 mmol, 3.0 equiv.) 
under dry argon. The resulting white mixture was cooled to 0 °C before anhydrous aluminum 
trichloride (1.688 g, 12.66 mmol, 1.2 equiv.) is added in one portion. The reaction mixture is 
stirred over a period of 4 h before allowing it to warm to room temperature for 16 h. The reaction 
was poured in ice and 10 mL of concentrated hydrochloric acid was added under stirring at 0 °C. 
The organic layer was separated and the aqueous layer was extracted with DCM twice (2 x 30 
mL). The combined organic layers were washed with water, dried over MgSO4 and concentrated 
to give the expected compound 20 (1.70 g, 7.72 mmol, 73 % yield).  
1
H NMR (400 MHz, 
CDCl3) δ 7.96 (d, J = 8.3 Hz, 2H, ArH), 7.60 – 7.54 (m, 1H, ArH), 7.46 (t, J = 7.6 Hz, 2H, ArH), 
3.12 (s, 2H, CH2CO2H), 2.59 (s, 2H, C=CCH2CMe2), 1.18 (s, 6H, 2Me). NMR data correspond to 
the reported values.
[7] 
 
4-Oxo-6-phenylhex-5-ynoic acid (22) 
 
To a solution of succinic anhydride 17 (1.2 g, 12 mmol, 1.2 equiv.) in DCM (125 mL) in a 
250mL round-bottom flask fitted with a thermometer, and solvent addition funnel was added 
aluminum trichloride (2.3 g, 17 mmol). The reaction mass was cooled under stirring to 15 °C and  
a solution of trimethyl(phenylethynyl)silane 21 (2.0 mL, 10 mmol) in 10mL of DCM was added 
dropwise and the reaction mixture was stirred for 16 h at rt. The reaction was poured in ice and 
10 mL of concentrated hydrochloric acid was added under stirring at 0 °C. The organic layer was 
separated and the aqueous layer was extracted with DCM twice (2 x 50 mL). The combined 
organic layers were washed with water, dried over MgSO4 and concentrated to give the expected 
compound 22 (1.00 g, 4.95 mmol, 49 % yield). 
1
H NMR (400 MHz, CDCl3) δ 7.58 (d, J = 7.5 
Hz, 2H, ArH), 7.47 (t, J = 7.4 Hz, 1H, ArH), 7.39 (t, J = 7.5 Hz, 2H. ArH), 3.02 (t, J = 6.6 Hz, 
2H, CH2), 2.77 (t, J = 6.6 Hz, 2H, CH2). NMR data correspond to the reported values.
[8]
 
 
2-(4-Fluorobenzoyl)benzoic acid (24) 
 
A 100-mL, three-necked, round-bottomed flask is charged with powdered phthalic anhydride 23 
(3.26 g, 22.0 mmol, 1.0 equiv.)  and fluorobenzene 16b (6.00 mL, 66.0 mmol, 3.0 equiv.) under 
dry nitrogen. The resulting white mixture was cooled to 0 °C before anhydrous aluminum 
trichloride (4.40 g, 33.0 mmol, 1.5 equiv.) was added in one portion. The reaction mixture was 
stirred over a period of 1 hr before the reaction mixture is allowed to warm to room temperature 
for 16h. The reaction was poured in ice and 10 mL of concentrated hydrochloric acid was added 
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under stirring at 0 °C. The organic layer was separated and the aqueous layer was extracted with 
DCM twice (2 x 30 mL). The combined organic layers were washed with water, dried over 
MgSO4 and concentrated to give the expected compound 254 (2.35 g, 9.42 mmol, 42 % yield). 
1
H 
NMR (400 MHz, CDCl3) δ 8.09 (d, J = 7.8 Hz, 1H, ArH), 7.74 (dd, J = 8.4, 5.5 Hz, 2H, ArH), 
7.68 (t, J = 7.5 Hz, 1H, ArH), 7.58 (t, J = 7.7 Hz, 1H, ArH), 7.36 (d, J = 7.5 Hz, 1H, ArH), 7.08 
(t, J = 8.5 Hz, 2H, ArH). NMR data correspond to the reported values.
 [9]
 
 General procedure for synthesis of enoic acid using Wittig reaction b.
Under nitrogen, to a solution of tBuOK (2.6 equiv.) in dry THF (0.5 M) was added 
bromo(methyl)triphenylphosphorane (1.3 equiv.) in portions at 0 °C. The mixture was stirred at 0 
°C for 30 min and a solution of ketone (1.0 equiv.) in dry THF (1 M) was added dropwise and the 
reaction was stirred at 0 °C for 1 h and at rt overnight. The solvent was removed in vacuo and the 
residue diluted with DCM and aqueous NaOH (1 M). The aqueous layer was separated, washed 
with dichloromethane, and acidified to pH 1 with concentrated HCl. DCM was added and the 
organic compound was extracted twice with DCM. The organic layer was washed with water, 
dried over MgSO4 and concentrated. The crude product was purified by SiO2 column 
chromatography (DCM/MeOH: 100/0 to 95/5 to 9/1) to give pure enoic acid. 
 
4-Phenylpent-4-enoic acid (1a) 
 
According to the general procedure, starting from 4-oxo-4-phenylbutanoic acid (3.00 g, 16.8 
mmol, 1.0 equiv.), tBuOK (4.91 g, 43.8 mmol, 2.6 equiv.) and 
bromo(methyl)triphenylphosphorane (7.82 g, 21.9 mmol, 1.3 equiv.), the product was obtained as 
a white solid (2.75 g, 15.6 mmol, 93 % yield). 
1
H NMR (400 MHz, CDCl3) δ 11.60 (bs, 1H), 
7.46 – 7.27 (m, 5H, ArH), 5.35 (s, 2H, C=CH2), 2.87 (t, J = 7.8 Hz, 2H, CH2CH2CO2H), 2.56 
(dd, J = 8.9, 6.7 Hz, 2H, CH2CH2CO2H). 
13
C NMR (101 MHz, CDCl3) δ 179.9, 146.6, 140.5, 
128.6, 127.8, 126.2, 113.1, 33.1, 30.2. NMR data correspond to the reported values. 
[10] 
 
 
4-(p-Tolyl)pent-4-enoic acid (1b) 
 
According to the general procedure, starting from 4-oxo-4-(p-tolyl)butanoic acid (2.00 g, 10.2 
mmol, 1.0 equiv.), tBuOK (3.00 g, 26.7 mmol, 2.6 equiv.) and 
bromo(methyl)triphenylphosphorane (4.78 g, 13.4 mmol, 1.3 equiv.), the product was obtained as 
a white solid (1.70 g, 8.94 mmol, 87 % yield). 
1
H NMR (400 MHz, CDCl3) δ 7.33 (d, J = 8.2 Hz, 
2H, ArH), 7.17 (d, J = 8.0 Hz, 2H, ArH), 5.33 (d, J = 1.0 Hz, 1H, C=CH2), 5.09 (q, J = 1.2 Hz, 
1H, C=CH2), 2.90 – 2.83 (m, 2H, CH2CH2CO2H), 2.61 – 2.52 (m, 2H, CH2CH2CO2H), 2.38 (s, 
3H, Me). 
13
C NMR (101 MHz, CDCl3) δ 179.8, 146.4, 137.6, 137.5, 129.2, 126.0, 112.3, 33.2, 
30.2, 21.2. NMR data correspond to the reported values. 
[11] 
 
 
S10 
 
4-(4-Methoxyphenyl)pent-4-enoic acid (1c) 
 
According to the general procedure, starting from 4-(4-methoxyphenyl)-4-oxobutanoic acid 18a 
(1.10 g, 5.28 mmol, 1.0 equiv.), tBuOK (1.54 g, 13.7 mmol, 2.6 equiv.) and 
bromo(methyl)triphenylphosphorane (2.45 g, 6.87 mmol, 1.3 equiv.), the product was obtained as 
a white solid (0.71 g, 3.44 mmol, 65 % yield). 
1
H NMR (400 MHz, CDCl3) δ 7.39 – 7.30 (m, 2H, 
ArH), 6.91 – 6.83 (m, 2H, ArH), 5.25 (d, J = 1.0 Hz, 1H, C=CH2), 5.03 (d, J = 1.2 Hz, 1H, 
C=CH2), 3.82 (s, 3H, Me), 2.88 – 2.75 (m, 2H, CH2CH2CO2H), 2.64 – 2.43 (m, 2H, 
CH2CH2CO2H). 
13
C NMR (101 MHz, CDCl3) δ 178.9, 159.4, 146.0, 133.0, 127.3, 113.9, 111.6, 
55.4, 33.1, 30.3. NMR data correspond to the reported values.
[11] 
 
4-(4-Bromophenyl)pent-4-enoic acid (1d) 
 
According to the general procedure, starting from 4-(4-bromophenyl)-4-oxobutanoic acid 18c 
(2.00 g, 7.78 mmol, 1.0 equiv.), tBuOK (2.27 g, 20.2 mmol, 2.6 equiv.) and 
bromo(methyl)triphenylphosphorane (3.61 g, 10.1 mmol, 1.3 equiv.), the product was obtained as 
a white solid (1.50 g, 5.88 mmol, 76 % yield. 
1
H NMR (400 MHz, (CD3)2SO) δ 12.18 (s, 1H, 
CO2H), 7.59 – 7.50 (m, 2H, ArH), 7.45 – 7.38 (m, 2H, ArH), 5.39 (s, 1H, C=CH2), 5.13 (d, J = 
1.4 Hz, 1H, C=CH2), 2.70 (t, J = 7.6 Hz, 2H, CH2CH2CO2H), 2.36 (dd, J = 8.4, 6.7 Hz, 2H, 
CH2CH2CO2H).
 13C NMR (101 MHz, (CD3)2SO) δ 173.8, 145.4, 139.3, 131.4, 128.0, 120.8, 
113.3, 32.5, 29.4. NMR data correspond to the reported values.
[12]
 
 
4-(4-Fluorophenyl)pent-4-enoic acid (1e) 
 
According to the general procedure, starting from 4-(4-fluorophenyl)-4-oxobutanoic acid 18b 
(2.00 g, 10.2 mmol), 1.0 equiv.), tBuOK (2.97 g, 26.5 mmol, 2.6 equiv.) and 
bromo(methyl)triphenylphosphorane (4.73 g, 13.2 mmol, 1.3 equiv.), the product was obtained as 
a white solid (1.70 g, 8.75 mmol, 86 % yield). 
1
H NMR (400 MHz, CDCl3) δ 7.41 – 7.32 (m, 2H, 
ArH), 7.02 (t, J = 8.7 Hz, 2H, ArH), 5.27 (s, 1H, C=CH2), 5.09 (s, 1H, C=CH2), 2.81 (t, J = 7.7 
Hz, 2H, CH2CH2CO2H), 2.51(t, J = 7.9 Hz, 2H, CH2CH2CO2H).
 13
C NMR (101 MHz, CDCl3) δ 
179.7, 162.5 (d, J = 246.6 Hz), 145.6, 136.6 (d, J = 3.3 Hz), 127.8 (d, J = 8.0 Hz), 115.4 (d, J = 
21.3 Hz), 113.1, 33.0, 30.3. NMR data correspond to the reported values.
[11]
 
 
4-(4-Chlorophenyl)pent-4-enoic acid (1f) 
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According to the general procedure, starting from 4-(4-chlorophenyl)-4-oxobutanoic acid 18d 
(1.65 g, 7.78 mmol, 1.0 equiv.), tBuOK (2.27 g, 20.2 mmol, 2.6 equiv.) and 
bromo(methyl)triphenylphosphorane (3.61 g, 10.1 mmol, 1.3 equiv.), the product was obtained as 
a white solid (1.0 g, 4.8 mmol, 61 % yield).  1H NMR (400 MHz, CDCl3) δ 7.35 – 7.28 (m, 4H, 
ArH), 5.31 (s, 1H, C=CH2), 5.12 (d, J = 1.3 Hz, 1H, C=CH2), 2.81 (t, J = 7.4 Hz, 2H, 
CH2CH2CO2H), 2.52 (m, 2H, CH2CH2CO2H).
 13
C NMR (101 MHz, CDCl3) δ 178.8, 145.6, 
139.0, 133.7, 128.7, 127.5, 113.7, 32.9, 30.1. NMR data correspond to the reported values.
[11]
 
 
2-(Prop-1-en-2-yl)benzoic acid (1g) 
  
According to the general procedure, starting from 2-acetylbenzoic acid (1.70 g, 10.3 mmol, 1.0 
equiv.), tBuOK (3.02 g, 26.9 mmol, 2.6 equiv.) and bromo(methyl)triphenylphosphorane (4.81 g, 
13.5 mmol, 1.3 equiv.), the product was obtained as a white solid (1.5 g, 9.3 mmol, 89 % yield).  
1
H NMR (400 MHz, CDCl3) δ 7.96 (d, J = 7.6 Hz, 1H, ArH), 7.51 (t, J = 7.5 Hz, 1H, ArH), 7.36 
(t, J = 7.6 Hz, 1H, ArH), 7.27 (d, J = 7.5 Hz, 1H, ArH), 5.13 (s, 1H, C=CH2), 4.90 (s, 1H, 
C=CH2), 2.13 (s, 3H, Me). 
13
C NMR (101 MHz, CDCl3) δ 173.7, 146.8, 146.5, 132.8, 130.9, 
129.9, 128.2, 127.2, 114.1, 24.5. NMR data correspond to the reported values. 
[10]  
 
2-(1-Phenylvinyl)benzoic acid (1h) 
 
According to the general procedure, starting from 2-benzoylbenzoic acid (1.50 g, 6.63 mmol, 1.0 
equiv.), tBuOK (1.93 g, 17.2 mmol, 2.6 equiv.) and bromo(methyl)triphenylphosphorane (3.08 g, 
8.62 mmol, 1.3 equiv.), the product was obtained as a white solid (0.60 g, 2.7 mmol, 40 % yield).  
1
H NMR (400 MHz, CDCl3) δ 7.93 (dd, J = 7.8, 1.4 Hz, 1H, ArH), 7.57 (td, J = 7.5, 1.5 Hz, 1H, 
ArH), 7.43 (td, J = 7.6, 1.4 Hz, 1H, ArH), 7.38 (dd, J = 7.6, 1.3 Hz, 1H, ArH), 7.28 – 7.18 (m, 
5H, ArH), 5.67 (d, J = 1.0 Hz, 1H, C=CH2), 5.23 (d, J = 1.0 Hz, 1H, C=CH2). 
13
C NMR (101 
MHz, CDCl3) δ 172.4, 149.6, 143.7, 141.0, 132.5, 131.7, 130.8, 129.6, 128.20, 127.8, 127.6, 
127.0, 114.5. NMR data correspond to the reported values.
 [10]
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2-(1-(4-Fluorophenyl)vinyl)benzoic acid (1i) 
 
According to the general procedure, starting from 2-(4-fluorobenzoyl)benzoic acid 24 (1.50 g, 
6.14 mmol, 1.0 equiv.), tBuOK (1.79 g, 15.9 mmol, 2.6 equiv.) and 
bromo(methyl)triphenylphosphorane (2.85 g, 7.98 mmol, 1.3 equiv.), the product was obtained as 
a white solid (0.25 g, 1.0 mmol, 17 % yield). 
1
H NMR (400 MHz, CDCl3) δ 7.93 (dd, J = 7.8, 1.5 
Hz, 1H, ArH), 7.57 (td, J = 7.5, 1.4 Hz, 1H, ArH), 7.44 (td, J = 7.6, 1.4 Hz, 1H, ArH), 7.36 (dd, J 
= 7.6, 1.3 Hz, 1H, ArH), 7.21 – 7.12 (m, 2H, ArH), 6.97 – 6.85 (m, 2H, ArH), 5.60 (d, J = 0.9 
Hz, 1H, C=CH2), 5.20 (s, 1H, C=CH2). 
13
C NMR (101 MHz, CDCl3) δ 172.7, 162.4 (d, J = 246.6 
Hz), 148.7, 143.6, 137.3 (d, J = 3.3 Hz), 132.7, 131.6, 130.9, 129.5, 128.5 (d, J = 8.0 Hz), 128.0 
115.0 (d, J = 21.5 Hz), 114.3. NMR data correspond to the reported values.
 [13]
 
 
2,2-Dimethyl-4-phenylpent-4-enoic acid (1j) 
 
Following a modified version of a reported procedure,
[14]
 N-Bromosuccinimide (2.46 g, 13.8 
mmol, 2.0 equiv.) and p-toluenesulfonic acid hydrate (0.263 g, 1.38 mmol, 0.2 equiv.) were 
dissolved in dry THF (20 mL), giving a yellow solution. Alpha methyl styrene 25 (0.90 mL, 6.9 
mmol, 1.0 equiv) was added via syringe: the reaction mixture became colorless. The latter was 
then submitted to irradiation in a microwave reactor at 130 °C for 3 h. The mixture was then 
allowed to cool down to room temperature and poured into pentane. A solid immediately 
precipitated. The organic layer was washed with water (4 x 20 mL) and brine (once), finally 
becoming a clear solution. The latter was dried over MgSO4, filtered and concentrated in vacuo to 
provide a yellow oil. The latter was submitted to column chromatography (SiO2, pentane, (Rf = 
0.95)) to provide pure (3-bromoprop-1-en-2-yl)benzene 26 (0.750 g, 3.81 mmol, 55% yield) as a 
colorless oil.
 1
H NMR (400 MHz, CDCl3) δ 7.52 - 7.48 (m, 2H, ArH), 7.41 - 7.33 (m, 3H, ArH), 
5.56 (s, 1H, C=CH2), 5.50 (s, 1H, C=CH2), 4.39 (s, 2H, CH2). NMR data correspond to the 
reported values.
[14]
 Following a standard procedure, diisopropylamine (freshly distilled over 
CaH2; 0.50 mL, 3.5 mmol, 1.1 equiv.) was dissolved in dry THF (3.2 mL) and the resulting 
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solution was cooled to -78 °C (dry ice-acetone bath). nBuLi (2.5 M in hexane; 1.3 mL, 3.3 mmol, 
1.05 equiv.) was added dropwise at the same temperature. The mixture was then stirred at 0 °C 
for 40 min, before being cooled back to -78 °C. Ethyl isobutyrate (0.44 mL, 3.2 mmol, 1.0 
equiv.) was added dropwise to the so-obtained LDA solution and the resulting mixture was 
stirred at -78 °C for 1 h and then treated with tetrabutylammonium iodide (0.234 g, 0.634 mmol, 
0.20 equiv.) and (3-bromoprop-1-en-2-yl)benzene 26 (0.750 g, 3.81 mmol, 1.2 equiv.). After 30 
min, the mixture was warmed to room temperature and stirred for another 15 h. After this time, 
the mixture was diluted with Et2O and the reaction was quenched by addition of water. The 
aqueous layer was extracted with Et2O (3 x 10 mL) and the combined organic extracts were 
washed with brine (once), dried over MgSO4, filtered and concentrated in vacuo. The resulting 
crude oil was submitted to column chromatography (SiO2; pentane/EtOAc 24/1) to provide pure 
ethyl 2,2-dimethyl-4-phenylpent-4-enoate 27 (0.650 g, 2.80 mmol, 88% yield) (Rf 0.80 
Pentane/EtOAc 5/1) as a colorless oil. 
1
H NMR (400 MHz, CDCl3) δ 7.35 - 7.20 (m, 5H, ArH), 
5.22 (d, J = 1.7 Hz, 1H, C=CH2), 5.04 (m, 1H, C=CH2), 3.73 (q, J = 7.1 Hz, 2H, CH2CH3), 2.79 
(s, 2H, CH2), 1.16 - 1.07 (m, 9H, CH2CH3 + CMe2). NMR data correspond to the reported 
values.
[15]
 Following a standard procedure, ethyl 2,2-dimethyl-4-phenylpent-4-enoate 27 (0.466 
g, 2.01 mmol, 1.0 equiv.) was dissolved in MeOH (4.0 mL). The solution was cooled to 0 °C 
(ice/water bath) and a solution of KOH (0.56 g, 10 mmol, 5.0 equiv.) in water (0.80 mL) was 
slowly added. The cooling bath was removed and stirring was continued while heating the 
mixture at 50 °C for 3 h. During this time, the initial suspension converted into a pale yellow 
clear solution. The latter was then diluted with water and extracted with ether (2 x 20 mL). It was 
then acidified with concentrated aq. HCl until acidic pH and extracted with DCM (3 x 20 mL). 
The combined organic extracts were washed with brine, dried MgSO4, and concentrated in vacuo 
to provide pure 2,2-dimethyl-4-phenylpent-4-enoic acid 1j (0.370, 1.81 mmol, 90% yield) as an 
off-white oil, which became a pale pink crystalline solid on standing. 
1
H NMR (400 MHz, 
CDCl3) δ 11.10 (s, 1H, CO2H), 7.35 (m, 2H, ArH), 7.32 - 7.22 (m, 3H, ArH), 5.27 (d, J = 1.4 Hz, 
1H, C=CH2), 5.10 (s, 1H, C=CH2), 2.82 (s, 2H, CH2), 1.10 (s, 6H, CMe2). 
13
C NMR (101 MHz, 
CDCl3) δ 184.5, 145.9, 142.4, 128.2, 127.5, 126.8, 117.3, 45.3, 42.8, 25.2. NMR data correspond 
to the reported values.
[10]
 
 
4-(Thiophen-3-yl)pent-4-enoic acid (1k) 
 
Under nitrogen, to a solution of ethyl acetate 28 (1.9 mL, 20 mmol, 1.1 equiv.) in 50 mL of dry 
THF was added lithium diisopropylamide (2 M solution in THF, 10.0 mL, 20.0 mmol, 1.1 equiv.) 
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dropwise and the reaction was stirred at -78 °C for 1 h. To the reaction was added 2,3-
dibromoprop-1-ene 29 (2.10 mL, 18.2 mmol, 1.0 equiv.) and the reaction was stirred for an 
additional 2 h at -78 °C. The reaction was warmed at rt and water (20 mL) was added slowly. The 
crude product was extracted with EtOAc three times (3 x 20 mL). The combined organic extracts 
were washed with brine, dried over MgSO4, filtered, and concentrated under reduced pressure. 
The resulting oil was purified by SiO2 column chromatography (Pentane/AcOEt : 100/0 to 95/5 
to 9/1) to give ethyl 4-bromopent-4-enoate  30 (0.770 g, 3.72 mmol, 20 % yield). 1H NMR (400 
MHz, CDCl3) δ 5.63 (s, 1H, C=CH2), 5.43 (s, 1H, C=CH2), 4.13 (t, J = 7.2 Hz, 2H, CH2CH3), 
2.75 (t, J = 7.5 Hz, 2H, CH2CO2Et), 2.57 (t, J = 7.5 Hz, 2H, CH2), 1.26 (t, J = 7.2 Hz, 3H, 
CH2CH3). NMR data correspond to the reported values.
[16]
 Following a reported procedure,
[11]
 
tetrakis palladium (0.127 g, 0.110 mmol, 5 mol %), sodium carbonate (anhydrous; 0.513 g, 4.84 
mmol. 2.2 equiv.), and thiophen-3-ylboronic acid 31 (0.338 g, 2.64 mmol, 1.2 equiv.) were 
suspended in a 7/1 mixture of dioxane (15.4 mL) and water (2.2 mL). Ethyl 4-bromopent-4-
enoate 30 (0.456 g, 2.20 mmol, 1.0 equiv.) was then added by syringe and the resulting yellow-
brown mixture was stirred under heating at 100 °C overnight. After 16 h, the reaction mixture 
was allowed to cool down to room temperature. The solvents were removed under reduced 
pressure and the residue was dissolved in EtOAc (30 mL). The organic solution was washed with 
water. The aqueous layer was then extracted with EtOAc (3 x 25 mL) and the combined extracts 
were washed with brine, dried over MgSO4, filtered and concentrated in vacuo. The resulting 
crude product was submitted to column chromatography (SiO2, pentane/EtOAc 24.6/0.4 to 24/1) 
to afford ethyl 4-(thiophen-3-yl)pent-4-enoate 32 (90% pure, 0.327g, 1.40 mmol, 65% yield) as a 
pale yellow oil. 
1
H NMR (400 MHz, CDCl3) δ 7.31-7.29 (m, 2H, ArH), 7.26 (d, J = 3.9 Hz, 1H, 
ArH), 5.40 (s, 1H, C=CH2), 5.06 (s, 1H, C=CH2), 4.16 (q, J = 7.1 Hz, 2H, OCH2CH3), 2.81 (m, 
2H, CH2), 2.58 (m, 2H, CH2), 1.28 (t, J = 7.1 Hz, 3H, OCH2CH3). NMR data correspond to the 
reported values.
[11]
 Following a standard procedure, ethyl 4-(thiophen-3-yl)pent-4-enoate 32 
(0.327 g, 1.55 mmol, 1.0 equiv.) was dissolved in MeOH (3.1 mL). The solution was cooled to 0 
°C and a solution of KOH (0.44 g, 7.8 mmol, 5.0 equiv.) in water (0.6 mL) was slowly added. 
The cooling bath was removed and stirring was continued at room temperature for 2 hours. The 
latter was then diluted with water and extracted with ether (3 x 20 mL). It was then acidified with 
concentrated aq. HCl until acidic pH and extracted with DCM (3 x 20 mL). The combined 
organic extracts were washed with brine, dried MgSO4, and concentrated in vacuo to provide a 
crude solid. The latter was submitted to recrystallization from hexane/chloroform (10/1, 5 mL) to 
afford 4-(Thiophen-3-yl)pent-4-enoic acid (1k) (90% pure, 0.200 g, 0.988 mmol, 63% yield) as 
an off-white solid. 
1
H NMR (400 MHz, CDCl3) δ 11.00 (br s, 1H, COOH), 7.29 (m, 1H, ArH), 
7.23 (d, J = 4.1 Hz, 2H, ArH), 5.40 (s, 1H, C=CH2), 5.06 (s, 1H, C=CH2), 2.81 (m, 2H, CH2), 
2.62 (m, 2H, CH2). 
13
C NMR (101 MHz, CDCl3) δ 179.9, 141.9, 141.0, 125.9, 125.8, 120.6, 
111.6, 33.1, 30.1. NMR data correspond to the reported values.
[11]
 
 
4-(2,5-Dimethylphenyl)pent-4-enoic acid (1l) 
 
According to the general procedure, starting from 4-(2,5-dimethylphenyl)-4-oxobutanoic acid 18e 
(1.55 g, 7.54 mmol, 1.0 equiv.), tBuOK (2.20 g, 19.6 mmol, 2.6 equiv.) and 
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bromo(methyl)triphenylphosphorane (3.50 g, 9.80 mmol, 1.3 equiv.), the product was obtained as 
a beige solid (1.25 g, 5.87 mmol, 78 % yield). Two rotamers are observed in NMR analysis. Only 
the major rotamer is described 
1
H NMR (400 MHz, CDCl3) δ 7.06 (d, J = 7.7 Hz, 1H, ArH), 
7.01 – 6.95 (m, 1H, ArH), 6.89 (d, J = 1.8 Hz, 1H, ArH), 5.21 (d, J = 1.7 Hz, 1H, C=CH2), 4.91 
(d, J = 1.7 Hz, 1H C=CH2), 2.66 (t, J = 7.7 Hz, 2H, CH2CH2CO2H), 2.47 (t, J = 7.8 Hz, 2H, 
CH2CH2CO2H), 2.30 (s, 3H, CH3), 2.24 (s, 3H, CH3).
 13
C NMR (101 MHz, CDCl3) δ 179.8, 
148.1, 141.9, 135.0, 131.8, 130.2, 129.1, 127.9, 114.5, 32.6, 32.6, 21.0, 19.4. IR 3079 (w), 2979 
(w), 2922 (w), 1708 (s), 1639 (w), 1499 (w), 1436 (w), 1295 (w), 1214 (w), 1159 (w), 916 (w). 
HRMS (ESI) calcd for C13H17O2
+
 [M+H]
+
 205.1223; found 205.1228. Melting point : 82 °C. 
 
2-(1-Methylene-2,3-dihydro-1H-inden-2-yl)acetic acid (1m) 
 
Under nitrogen, diisopropylamine (freshly distilled from CaH2; 1.12 mL, 7.94 mmol, 1.05 equiv.) 
was dissolved in dry THF (5.0 mL). The solution was cooled down to -70 °C and nBuLi (2.5 M in 
hexanes; 3.0 mL, 7.6 mmol, 1.0 equiv.) was added dropwise at the same temperature. Upon 
completing the addition, the resulting pale yellow solution was allowed to warm to 0 °C for 15 
min. It was then cooled back to -78 °C and added dropwise to a solution of 1-indanone 33 (1.00 
g, 7.57 mmol, 1.0 equiv.) in dry THF (24 mL). The mixture was stirred at -78 °C for 40 min. A 
solution of methyl bromoacetate 34 (0.76 mL, 7.9 mmol, 1.05 equiv.) in dry THF (6.0 mL) was 
then added dropwise. The resulting pale yellow solution was stirred overnight while allowing it to 
warm to room temperature. After 20 h, the mixture looked like a yellow clear solution. The 
reaction was quenched by addition of water, followed by sat. aq. NH4Cl. The aqueous layer was 
extracted with ether (3 x 30 mL) and the combined extracts were washed with water and brine, 
dried over MgSO4, filtered and concentrated in vacuo. The obtained crude oil was submitted to 
column chromatography (SiO2, pentane/EtOAc 24/1) to afford the pure methyl 2-(1-oxo-2,3-
dihydro-1H-inden-2-yl)acetate 35 (0.593 g, 2.90 mmol, 38% yield) as a pale yellow oil. Rf 0.85 
(Pentane/EtOAc 5/1)
 1
H NMR (400 MHz, CDCl3) δ 7.77 (d, J = 7.7 Hz, 1H, ArH), 7.60 (t, J = 
7.4 Hz, 1H, ArH), 7.46 (d, J = 7.7 Hz, 1H, ArH), 7.38 (t, J = 7.4 Hz, 1H, ArH), 3.69 (s, 3H, 
OCH3), 3.47 (dd, J = 17.1, 8.0 Hz, 1H, CH2), 3.08 - 2.95 (m, 2H, CH2 and CHCO), 2.89 (dd, J = 
17.1, 4.4 Hz, 1H, CH2), 2.62 (dd, J = 9.1, 17.1 Hz, 1H, CH2). NMR data correspond to the 
reported values.
[17]
 Following a standard procedure, potassium tert-butoxide (0.652 g, 5.81 mmol, 
2.0 equiv.) was suspended in dry THF (14.5 mL). The suspension was cooled to 0 °C and 
methyltriphenylphosphonium bromide (2.18 g, 6.10 mmol, 2.1 equiv.) was added, leading to the 
formation of a bright yellow suspension. The latter was stirred at 0 °C for 30 min. A solution of 
methyl 2-(1-oxo-2,3-dihydro-1H-inden-2-yl)acetate 35 (0.593 g, 2.90 mmol, 1.0 equiv.) in dry 
THF (1.0 mL) was then added at the same temperature. The reaction mixture was allowed to 
warm to room temperature and stirred overnight. The reaction was quenched by addition of sat. 
aq. NH4Cl at 0 °C. The aqueous layer was extracted with Et2O (3 x 15 mL) and the combined 
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organic extracts were washed with brine, dried over MgSO4, filtered and concentrated in vacuo to 
give a yellow crude solid. The latter was submitted to column chromatography (SiO2, 
pentane/EtOAc 24/1 to 23/2) (Rf = 0.35 Pentane/EtOAc : 9/1) to afford pure compound 36 (0.257 
g, 1.27 mmol, 44% yield) as a pale yellow oil. 
1
H NMR (400 MHz, CDCl3) δ 7.48 (d, J = 6.8 Hz, 
1H, ArH), 7.23-7.19 (m, 3H, ArH), 5.51 (d, J = 1.4 Hz, 1H, C=CH2), 5.00 (s, 1H, C=CH2), 3.71 
(s, 3H, OCH3), 3.43 (m, 1H, CH), 3.28 (dd, J = 8.4, 16.4 Hz, 1H, CH2), 2.73 (m, 1H, CH2), 2.69 
(m, 1H, CH2), 2.46 (dd, J = 9.6, 15.7 Hz, 1H, CH2).  Following a standard procedure, methyl 2-
(1-methylene-2,3-dihydro-1H-inden-2-yl)acetate 36 (0.257 g, 1.27 mmol, 1.0 equiv.) was 
dissolved in MeOH (2.6 mL). The solution was cooled to 0 °C and a solution of KOH (0.36 g, 6.3 
mmol, 5.0 equiv.) in water (0.5 mL) was slowly added. The cooling bath was removed and 
stirring was continued at room temperature for 2 hours. During this time, the initial suspension 
converted into a pale yellow clear solution. The latter was then diluted with water and extracted 
with ether (3 x 10 mL). It was then acidified with concentrated aq. HCl until acidic pH and 
extracted with DCM (3 x 10 mL). The combined organic extracts were washed with brine, dried 
MgSO4, concentrated in vacuo to provide pure 2-(1-methylene-2,3-dihydro-1H-inden-2-yl)acetic 
acid (1m) (90% pure, 0.195 g, 1.04 mmol, 82% yield) as a colorless oil. 
1
H NMR (400 MHz, 
CDCl3) δ 9.88 (br s, 1 H, CO2H), 7.51 (d, J = 6.8 Hz, 1H, ArH), 7.35 - 7.17 (m, 3H, ArH), 5.56 
(s, 1H, C=CH2), 5.06 (s, 1H, C=CH2), 3.42 (d, J = 9.7 Hz, 1H, CH or ArCH2), 3.34 (dd, J = 16.3, 
8.5 Hz, 1H, CH2CO), 2.80 (d, J = 5.4 Hz, 1H, CH or ArCH2), 2.78 (d, J = 6.0 Hz, 1H, CH or 
ArCH2), 2.53 (dd, J = 16.1, 9.6 Hz, 1H, CH2CO). 
13
C NMR (101 MHz, CDCl3) δ 178.9, 152.8, 
144.3, 140.2, 128.9, 126.9, 125.5, 121.0, 103.4, 40.2, 39.3, 37.4. IR 3519 (w), 2923 (s), 2852 
(m), 2851 (m), 2360 (w), 2360 (w), 2343 (w), 2342 (w), 1741 (s), 1639 (w), 1439 (m), 1411 (m), 
1303 (m), 1280 (m), 1257 (m), 1211 (m), 1210 (m), 957 (w), 875 (m). HRMS (ESI) calcd for 
C12H11O2
+
 [M+] 187.0759; found 187.0760. 
 
4-Methylene-6-phenylhex-5-ynoic acid (1n) 
 
According to the general procedure, starting from 4-oxo-6-phenylhex-5-ynoic acid 22 (0.50 g, 2.4 
mmol, 1.0 equiv.), tBuOK (0.721 g, 6.43 mmol, 2.6 equiv.) and 
bromo(methyl)triphenylphosphorane (1.15 g, 3.21 mmol, 1.3 equiv.), the product was obtained as 
a brown solid (0.35 g, 1.8 mmol, 71 % yield). 
1
H NMR (400 MHz, CDCl3) δ 7.48 – 7.41 (m, 2H, 
ArH), 7.35 – 7.29 (m, 3H, ArH), 5.47 (d, J = 1.5 Hz, 1H, C=CH2), 5.38 (d, J = 1.4 Hz, 1H, 
C=CH2), 2.68 (ddd, J = 8.4, 7.0, 1.7 Hz, 2H, CH2CH2CO2H), 2.63 – 2.54 (m, 2H, 
CH2CH2CO2H). 
13
C NMR (101 MHz, CDCl3) δ 179.2, 131.7, 129.6, 128.4, 128.5, 123.0, 122.3, 
90.2, 88.7, 33.0, 32.1. NMR data correspond to the reported values.
[18] 
 
 
5-Phenylhex-5-enoic acid (1o) 
 
According to the general procedure, starting from 5-oxo-5-phenylpentanoic acid (1.50 g, 7.80 
mmol, 1.0 equiv.), tBuOK (2.28 g, 20.3 mmol, 2.6 equiv.) and 
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bromo(methyl)triphenylphosphorane (3.62 g, 10.1 mmol, 1.3 equiv.), the product was obtained as 
a white solid (0.40 g, 2.1 mmol, 27 % yield). 
1
H NMR (400 MHz, CDCl3) δ 7.45 – 7.41 (m, 2H, 
ArH), 7.38 – 7.33 (m, 2H, ArH), 7.32 – 7.27 (m, 1H, ArH), 5.35 (d, J = 1.3 Hz, 1H, C=CH2), 
5.12 (d, J = 1.4 Hz, 1H, C=CH2), 2.61 (td, J = 7.5, 1.2 Hz, 2H, CH2CH2CH2CO2H), 2.41 (t, J = 
7.4 Hz, 2H, CH2CH2CH2CO2H), 1.83 (p, J = 7.5 Hz, 2H, CH2CH2CH2CO2H). 
13
C NMR (101 
MHz, CDCl3) δ 180.3, 147.4, 140.8, 128.5, 127.6, 126.2, 113.2, 34.5, 33.4, 23.1. NMR data 
correspond to the reported values.
[19]
 
 
3,3-Dimethyl-5-phenylhex-5-enoic acid (1p) 
 
According to the general procedure, starting from 3,3-dimethyl-5-oxo-5-phenylpentanoic acid 20 
(1.70 g, 7.72 mmol, 1.0 equiv.), tBuOK (2.25 g, 20.1 mmol, 2.6 equiv.) and 
bromo(methyl)triphenylphosphorane (3.58 g, 10.0 mmol, 1.3 equiv.), the product was obtained as 
a white solid (0.35 g, 1.6 mmol, 21 % yield).  
1
H NMR (400 MHz, CDCl3) δ 7.38 – 7.33 (m, 2H, 
ArH), 7.30 – 7.26 (m, 2H, ArH), 7.25 – 7.20 (m, 1H, ArH), 5.29 (d, J = 2.0 Hz, 1H, C=CH2), 
5.09 (d, J = 1.9 Hz, 1H, C=CH2), 2.65 (s, 2H, CH2CO2H), 2.18 (s, 2H, H2C=CCH2), 0.92 (s, 6H, 
Me2). 
13
C NMR (101 MHz, CDCl3) δ 179.3, 146.6, 143.3, 128.3, 127.3, 126.6, 117.6, 46.9, 45.9, 
34.2, 27.8. NMR data correspond to the reported values.
[19] 
 
2-((2-Phenylallyl)oxy)acetic acid (1q) 
 
In an oven dried flask, prop-1-en-2-ylbenzene 25 (2.00 mL, 15.4 mmol, 1.0 equiv.) was diluted in 
dry THF (5 mL) and NBS (2.88 g, 16.2 mmol, 1.05 equiv.) and 4-methylbenzenesulfonic acid 
(2.65 g, 15.4 mmol, 1.0 equiv.) were added and the solution was refluxed at 100 °C for 4 h. The 
reaction mixture was cooled to rt and then diluted with Pentane/Et2O (1/1: 20 mL), washed with 
H2O. The organic layer was dried over MgSO4 and concentrated under reduced pressure to obtain 
a yellow oil. Purification by column chromatography over silica gel using Pentane (Rf = 0.95) as 
eluent afforded (3-bromoprop-1-en-2-yl)benzene  26 (1.43 g, 7.26 mmol, 47 % yield). 
1
H NMR 
(400 MHz, CDCl3) δ 7.53 – 7.47 (m, 2H, ArH), 7.42 – 7.30 (m, 3H, ArH), 5.56 (s, 1H, C=CH2), 
5.50 (s, 1H, C=CH2), 4.39 (s, 2H, CH2). NMR data correspond to the reported values.
[14]
 To the 
suspension of sodium hydride (104 mg, 2.60 mmol, 1.3 equiv.) in dry THF (4 mL) was added 
methyl 2-hydroxyacetate 36 (200 µl, 2.60 mmol, 1.3 equiv.) at 0 °C under nitrogen. The resulting 
mixture was stirred for 30 min at the same temperature. (3-bromoprop-1-en-2-yl)benzene 27 (394 
mg, 2.00 mmol, 1.0 equiv.) was then added to the reaction mixture. The mixture was allowed to 
warm to rt and stirred for 10 h. The reaction was quenched with saturated NH4Cl aqueous 
solution. The organic layer was extracted with AcOEt twice (2 x 10mL), washed with brine, dried 
over with Na2SO4 and concentrated in vacuo. The residue was purified by SiO2 column 
chromatography (Pentane/AcOEt : 2/1) to give methyl 2-((2-phenylallyl)oxy)acetate 37 0.14 g, 
0.68 mmol, 34 % yield). 
1
H NMR (400 MHz, CDCl3) δ 7.51 (d, J = 7.4 Hz, 2H, ArH), 7.35 (t, J 
= 7.3 Hz, 2H, ArH), 7.32 – 7.28 (m, 1H, ArH), 5.59 (s, 1H, C=CH2), 5.36 (s, 1H, C=CH2), 4.52 
S18 
 
(s, 2H, OCH2CO2Me), 4.13 (s, 2H, OCH2), 3.76 (s, 3H, CO2Me). NMR data correspond to the 
reported values.
[20]
 A mixture of methyl 2-((2-phenylallyl)oxy)acetate 37 (140 mg, 0.679 mmol, 
1.0 equiv.) and lithium hydroxide (81.0 mg, 3.39 mmol, 5.0 equiv.) in MeOH (7 mL) was stirred 
for 1 h at 50 °C. The reaction mixture was cooled to rt and acidified with 10% HCl aqueous 
solution. The product was then extracted with DCM (3 x 10 mL) and dried over with MgSO4 and 
concentrated in vacuo. The residue was purified by SiO2 column chromatography 
(Pentane/AcOEt : 1/1) to give 2-((2-phenylallyl)oxy)acetic acid 1q (110 mg, 0.572 mmol, 84 % 
yield) as yellow oil. 
1
H NMR (400 MHz, CDCl3) δ 7.48 (dd, J = 8.2, 1.8 Hz, 2H, ArH), 7.41 – 
7.29 (m, 3H, ArH), 5.60 (s, 1H, C=CH2), 5.36 (s, 1H, C=CH2), 4.54 (s, 2H, OCH2CO2Me), 4.15 
(s, 2H, OCH2). 
13
C NMR (101 MHz, CDCl3) δ 175.4, 143.1, 138.1, 128.6, 128.2, 126.2, 115.9, 
73.5, 66.5. NMR data correspond to the reported values.
 [20] 
 
4-Benzylpent-4-enoic acid (1r)
 
To a suspension of copper iodide (2.00 g, 10.5 mmol, 1.2 equiv.)  in dry THF (17 mL) was added 
a solution of benzylmagnesium chloride 38 (2M in THF)  (5.25 mL, 10.5 mmol, 1.2 equiv.)  was 
added dropwise between 0 °C and -20 °C. The mixture was stirred between 0 °C and -20 °C for 
0.5 h. After cooled at -78 °C, a solution of methyl 4-chloro-4-oxobutanoate 39 (1.00 mL, 8.12 
mmol, 1.0 equiv.) in THF (10 mL) was added and the reaction was stirred at -78 °C for 2 h and at 
room temperature for 30 min. NH4Cl aq. solution was added to quench the reaction. EtOAc (30 
mL) was added and the organic layer was extracted twice with EtOAc (2 x 20 mL). The 
combined organic layers were washed with water, dried over MgSO4 and concentrated. The crude 
product was purified by flash SiO2 column (Pentane/EtOAc : 95/5 to 9/1) to give methyl 4-oxo-5-
phenylpentanoate 40 (1.20 g, 5.82 mmol, 67 % yield). 
1
H NMR (400 MHz, CDCl3) δ 7.37 - 7.30 
(m, 2H, ArH), 7.30 - 7.16 (m, 3H, ArH), 3.74 (s, 2H, CH2Ar), 3.65 (s, 3H, Me), 2.76 (t, J = 6.6 
Hz, 2H, CH2CH2COOMe), 2.56 (t, J = 6.6 Hz, 2H, CH2CH2COOMe).
13
C NMR (101 MHz, 
CDCl3) δ 206.4, 173.1, 134.0, 129.4, 128.7, 127.0, 51.7, 50.0, 36.4, 27.7. NMR data correspond 
to the reported values.
[21]
 Under nitrogen, to a suspension of bromo(methyl)triphenylphosphorane 
(1.82 g, 5.09 mmol, 1.5 equiv.) in dry THF (8 mL) was added dropwise a solution of sodium 
bis(trimethylsilyl)amide (2M in THF) (2.04 mL, 4.07 mmol, 1.2 equiv.) at 0 °C. The mixture was 
stirred at 0 °C for 0.5 h. Than a solution of methyl 4-oxo-5-phenylpentanoate 40 (0.700 g, 3.39 
mmol, 1.0 equiv.) in dry THF (8 mL) was added at 0 °C. The reaction was stirred at room 
temperature overnight. Solvent was removed in vacuo and the residue diluted with 
dichloromethane. The organic layer was washed with an aqueous 0.5 M NaOH solution, aqueous 
NH4Cl solution, brine, dried over MgSO4 and concentrated in vacuo. The crude product was 
purified by flash SiO2 column (Pentane/EtOAc : 95/5 to 9/1) to give methyl 4-benzylpent-4-
enoate 41 (0.140 g, 0.685 mmol, 20 % yield) as a colorless liquid. 
1
H NMR (400 MHz, CDCl3) δ 
7.32 – 7.27 (m, 2H, ArH), 7.24 – 7.15 (m, 3H, ArH), 4.83 (m, 1H, C=CH2), 4.81 (m, 1H, 
C=CH2), 3.65 (s, 3H, Me), 3.36 (s, 2H, CH2Ar), 2.49 – 2.42 (m, 2H, CH2CH2COOMe), 2.34 – 
2.26 (m, 2H, CH2CH2COOMe). 
13
C NMR (101 MHz, CDCl3) δ 173.7, 147.3, 139.4, 129.1, 
128.5, 126.3, 111.7, 51.7, 43.4, 32.5, 30.4. IR 3085 (w), 3063 (w), 3028 (w), 2987 (w), 2980 (w), 
2953 (w), 2911 (w), 2910 (w), 2904 (w), 2903 (w), 2871 (w), 2871 (w), 2870 (w), 2870 (w), 
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2853 (w), 2844 (w), 2843 (w), 2362 (w), 2342 (w), 2333 (w), 1741 (s), 1649 (w), 1456 (w), 1438 
(m), 1199 (w), 1198 (w), 1170 (w), 1042 (w), 912 (s). HRMS (ESI) calcd for 
C13H16NaO2+ [M+Na]
+
 227.1042; found 227.1047. To a solution of methyl 4-benzylpent-4-
enoate 41 (0.140 g, 0.685 mmol, 1.0 equiv.) in MeOH (1.5 mL) was added a solution of 
potassium hydroxide (0.173 g, 3.08 mmol, 4.5 equiv.) in water (0.5 mL) at 0 °C. After stirring for 
2 h at ambient temperature, the reaction was quenched with concentrated aqueous HCl. The 
mixture was extracted with AcOEt. The organic layers were dried over anhydrous Na2SO4, 
filtered and concentrated in vacuo. The residue was purified by flash SiO2 column (DCM/MeOH 
: 100 to 95/5) to give 4-benzylpent-4-enoic acid 1r (0.100 g, 0.526 mmol, 77 % yield) as a white 
oil. 
1
H NMR (400 MHz, CDCl3) δ 7.32 – 7.25 (m, 2H, ArH), 7.25 – 7.14 (m, 3H, ArH), 4.85 (d, 
J = 1.6 Hz, 1H, C=CH2), 4.83 (q, J = 1.2 Hz, 1H, C=CH2), 3.37 (s, 2H, ArCH2), 2.50 (m, 2H, 
CH2CH2CO2H), 2.30 (t, J = 7.7 Hz, 2H, CH2CH2CO2H). 
13
C NMR (101 MHz, CDCl3) δ 179.8, 
147.0, 139.3, 129.1, 128.5, 126.4, 111.9, 43.4, 32.5, 30.0. NMR data correspond to the reported 
values.
[22]
 
 
4-Methylene-7-phenylheptanoic acid (1s) 
 
Mg turnings (0.440 g, 18.0 mmol, 2.8 equiv.) and a crystal of iodine were suspended in THF (9.0 
mL). (3-Bromopropyl)benzene (1.76 mL, 11.6 mmol, 1.8 equiv.) was then added dropwise 
leading to the start of the reaction. In a two-necked round-bottomed flask, CuI (2.22 g, 11.7 
mmol, 1.8 equiv.) was suspended in THF (18 mL) and the resulting grey mixture was cooled 
down to 0 °C. The freshly prepared Grignard reagent was then slowly added, which was stirred at 
0 °C for 30 min. The mixture was then cooled to -78 °C and a solution of methyl succinyl 
chloride 39 (2.4 mL, 18 mmol, 1.0 equiv.) in THF (9.0 mL) was added dropwise. After stirring at 
-78 °C for 5 min, the mixture was warmed back to 0 °C and stirring was continued at this 
temperature for addition 60 min. The reaction was quenched by addition of water (20 mL), 
followed by aq. HCl (1.0 M; 20 mL), still at 0 °C. Diethyl ether was added. The aqueous layer 
was then separated and extracted with diethyl ether (2 x 20 mL). The combined organic layers 
were washed twice with sat. aq. NaHCO3, once with brine, dried over MgSO4, filtered and 
concentrated in vacuo to give a yellow crude oil. The latter was submitted to column 
chromatography (SiO2, Pentane/EtOAc 24/1 to 10/1) to afford pure methyl 4-oxo-7-
phenylheptanoate 42 (0.805 g, 3.44 mmol, 53% yield) as a pale yellow oil. 
1
H NMR (400 MHz, 
CDCl3) δ 7.33 – 7.25 (m, 2H, ArH), 7.23-7.14 (m, 3H, ArH), 3.68 (s, 3H, OCH3), 2.70 (t, J = 6.2 
Hz, 2H, COCH2CH2CO2Me), 2.63 (t, J = 7.5 Hz, 2H, COCH2CH2CH2Ph), 2.58 (t, J = 6.2 Hz, 
2H, COCH2CH2CO2Me), 2.47 (t, J = 7.4 Hz, 2H, COCH2CH2CH2Ph), 1.94 (pent, J = 7.4 Hz, 2H, 
COCH2CH2CH2Ph). NMR data correspond to the reported values. 
[23]
 Following a standard 
procedure, tBuOK (0.771 g, 6.87 mmol, 2.0 equiv.) was suspended in THF (17 mL). The 
suspension was cooled to 0 °C and methyltriphenylphosphonium bromide (2.58 g, 7.22 mmol, 
2.1 equiv.) was added, leading to the formation of a bright yellow suspension. The latter was 
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stirred at 0 °C for 30 minutes. A solution of methyl 4-oxo-7-phenylheptanoate 42 (0.805 g, 3.44 
mmol, 1.0 equiv.) in THF (1 mL) was then added at the same temperature. The reaction mixture 
was allowed to warm to room temperature and stirred overnight. The reaction was quenched by 
addition of sat. aq. NH
4
Cl at 0 °C. The aqueous layer was extracted with ether (3 x 15 mL) and 
the combined organic extracts were washed with brine, dried over MgSO4, filtered and 
concentrated in vacuo to give a yellow crude solid. The latter was submitted to column 
chromatography (SiO
2
, pentane/EtOAc 24.5/0.5 to 24/1) to afford methyl 4-methylene-7-
phenylheptanoate 43 (0.245 g, 1.06 mmol, 31% yield) as a pale yellow oil. 
1
H NMR (400 MHz, 
CDCl3) δ 7.32 - 7.23 (m, 2H, ArH), 7.22 - 7.14 (m, 3H), 4.78 (s, 1H, C=CH2), 4.75 (s, 1H, 
C=CH2), 3.67 (s, 3H, OCH3), 2.61 (t, J = 7.3 Hz, 2H, aliphatic CH2), 2.47 (m, 2H, aliphatic CH2), 
2.34 (t, J = 7.9 Hz, 2H, aliphatic CH2), 2.07 (t, J = 7.7 Hz, 2H, aliphatic CH2), 1.77 (p, J = 7.7, 
Hz, 2H, aliphatic CH2). Following a standard procedure, methyl 4-methylene-6-phenylheptanoate 
43 (0.245 g, 0.105 mmol, 1.0 equiv.) was dissolved in MeOH (2.2 mL). The solution was cooled 
to 0 °C and a solution of KOH (0.30 g, 5.3 mmol, 5.0 equiv.) in water (0.4 mL) was slowly 
added. The cooling bath was removed and stirring was continued at room temperature for 2 h. 
During this time, the initial suspension converted into a pale yellow clear solution. The mixture 
was then diluted with aq. NaOH (1.0 M) and extracted with ether (3 x 10 mL). It was then 
acidified with concentrated aq. HCl until pH < 3 and extracted with DCM (3 x 10 mL). The 
combined organic extracts were washed with brine, dried MgSO4, and concentrated in vacuo to 
provide pure 4-methylene-7-phenylheptanoic acid 1s (0.185 g, 0.847 mmol, 80% yield) as a 
colorless viscous oil. 
1
H NMR (400 MHz, (CD3)2CO) δ 10.53 (s, 1H, COOH), 7.30 – 7.19 (m, 
4H, ArH), 7.19 – 7.13 (m, 1H, ArH), 4.78 (dd, J = 2.4, 1.3 Hz, 2H, C=CH2), 2.67 – 2.57 (m, 2H, 
aliphatic CH2), 2.47 – 2.41 (m, 2H, aliphatic CH2), 2.38 – 2.29 (m, 2H, aliphatic CH2), 2.11 (t, J 
= 7.7 Hz, 2H, aliphatic CH2), 1.83 – 1.70 (m, 2H, aliphatic CH2). 
13
C NMR (100 MHz, 
(CD3)2CO) δ 174.3, 149.2, 143.4, 129.3, 129.2, 126.6, 109.9, 36.6, 36.7, 32.8, 31.6, 30.5. IR 
3074 (m), 3028 (m), 2932 (m), 2864 (m), 2672 (w), 1948 (w), 1708 (s), 1650 (w), 1607 (w), 1493 
(w), 1444 (m), 1295 (m), 1217 (w), 1165 (w), 1075 (w), 1026 (w), 936 (w), 896 (m). HRMS 
(ESI) calcd for C14H17O2
-
 [M+H-1]
-
 217.1234; found 217.1231. 
 
2-Allylbenzoic acid (1t) 
 
Under nitrogen, a solution of isopropylmagnesium chloride (2 M in THF, 5.25 mL, 10.5 mmol, 
1.5 equiv.) was added dropwise to a solution of methyl 2-iodobenzoate 13 (1 mL, 7 mmol, 1.0 
equiv.) in dry THF (75 mL) at -40 °C. The resulting mixture was stirred at -40 °C for 1.5 h. Then 
it was added via cannula to a freshly prepared solution of cyanocopper (627 mg, 7.00 mmol, 1.0 
equiv.) and lithium chloride (594 mg, 14.0 mmol, 2.0 equiv.) in dry THF (20 mL), followed by 
dropwise addition of 3-bromoprop-1-ene (2.42 mL, 28.0 mmol, 4.0 equiv.). After being stirred at 
-40 °C for 4 h, the mixture was allowed to warm to room temperature, diluted with EtOAc (50 
mL) and filtered over Celite. The organic solution was washed with a 25% ammonia aqueous 
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solution. The aqueous layer was extracted with EtOAc (3 x 30 mL). The combined organic layers 
were washed with brine, dried over MgSO4, filtered and concentrated in vacuo. The crude 
product was filtered through a short pad of silica eluting with Pentane/EtOAc = 20/1, and then 
dissolved in EtOH (50 mL). A 2M NaOH solution (50 mL) was added and the resulting mixture 
was stirred at room temperature for 4 h. EtOH was then removed under reduced pressure and the 
aqueous layer was washed with Et2O (3 x 20 mL). The aqueous solution was acidified to pH 3 
with 2 M HCl solution and extracted with Et2O (3 x 50 mL). The combined organic layers were 
dried over MgSO4, filtered and concentrated in vacuo. The residue was purified by flash SiO2 
column (DCM/MeOH : 100 to 95/5) to afford 2-allylbenzoic acid 1t (750 mg, 4.62 mmol, 66 % 
yield) (Rf = 0.4 DCM/MeOH : 95/5) as a white solid. 
1
H NMR (400 MHz, CDCl3) δ 12.49 (bs, 
1H, CO2H), 8.09 (dd, J = 8.1, 1.5 Hz, 1H, ArH), 7.52 (td, J = 7.5, 1.5 Hz, 1H, ArH), 7.39 – 7.29 
(m, 2H, ArH), 6.17 – 5.95 (m, 1H, CH=CH2), 5.09 (t, J = 1.5 Hz, 1H, C=CH2), 5.06 (dq, J = 7.6, 
1.6 Hz, 1H, C=CH2), 3.87 (dt, J = 6.4, 1.5 Hz, 2H). 
13
C NMR (101 MHz, CDCl3) δ 173.6, 142.9, 
137.6, 133.3, 131.7, 131.3, 128.4, 126.5, 115.7, 38.5. NMR data correspond to the reported 
values.
[24]  
 
2-(2-Methylallyl)benzoic acid (1u) 
 
Under nitrogen, nBuLi (2.5 M in hexanes, 6.1 mL, 15 mmol, 1.3 equiv) was added dropwise to a 
solution of 4,4-dimethyl-2-phenyl-2-oxazoline 44 (2.0 g, 11 mmol, 1.0 equiv) in dry THF (34 
mL, previously flushed with argon) at 0 °C. The mixture was stirred at 0 °C for 3h30 and then it 
was transferred to a suspension of CuBr (1.61 g, 11.2 mmol, 0.99 equiv) in dry THF (10 mL) via 
cannula. The resulting green mixture was stirred at 0 °C for 1h30, methallyl chloride (1.0 mL, 10 
mmol, 0.9 equiv) was added and the reaction mixture was stirred at rt overnight. The reaction was 
then quenched by addition of water (10 mL) and aqueous NH3 (25% v/v. solution, 10 mL). The 
aqueous layer was extracted with Et2O (3 x 20 mL) and the combined organic layers were 
washed with brine, dried over MgSO4, filtered and concentrated under reduced pressure. 
Purification of the crude product by column chromatography (SiO2, Hexane/EtOAc 10/1) 
afforded 4,4-dimethyl-2-(2-(2-methylallyl)phenyl)-4,5-oxazoline 45 (1.26 g, 5.49 mmol, 47 % 
yield) as a dark oil. Oxazoline 45 was converted to the methiodide salt by stirring in excess MeI 
(2.1 mL, 33 mmol, 6 equiv) and DMSO (1.2 mL) overnight at rt. The solvents were then 
evaporated in vacuo and the crude oxazoline methiodide was treated with aqueous NaOH (2.0 M; 
17.3 mL) at reflux for 9 h. The solution was then allowed to cool to rt and washed with CH2Cl2 (3 
x 20 mL). The aqueous layer was acidified to pH 1 with concentrated HCl and extracted with 
CH2Cl2 (3 x 25 mL). The combined organic layers were washed with brine, dried over MgSO4, 
filtered and concentrated in vacuo. The crude product was filtered on SiO2 to afford 2-(2-
methylallyl)benzoic acid 1u (0.53 g, 3.1 mmol, 55% yield) as a colorless solid. Rf 0.42 (28:12:1 
hexane/Et2O/HCO2H); 
1
H NMR (400 MHz, CDCl3) δ 11.2 (bs, 1H, CO2H), 8.03 (dd, J = 7.4, 0.9 
Hz, 1H, ArH), 7.49 (td, J = 7.6, 1.5 Hz, 1H, ArH), 7.36-7.26 (m, 2H, ArH), 4.80 (d, J = 0.7 Hz, 
1H, C=CH2), 4.47 (d, J = 0.7 Hz, 1H, C=CH2), 3.78 (s, 2H, CH2), 1.76 (s, 3H, CH3); 
13
C NMR 
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(100 MHz, CDCl3)  173.1, 145.4, 142.2, 132.7, 131.6, 131.5, 128.8, 126.3, 111.6, 41.8, 23.0. 
NMR data correspond to the reported values.
[25]
 
 
2-(2-((Benzyloxy)methyl)allyl)benzoic acid (1v) 
 
Following a standard procedure, 2-methylenepropane-1,3-diol 46 (0.70 mL, 8.6 mmol, 1.0 
equiv.) was dissolved in THF (dry; 26.8 mL) and the resulting solution was cooled to 0 °C. NaH 
(60% suspension in mineral oil; 0.343 g, 8.58 mmol, 1.0 equiv.) was then added, immediately 
resulting in vigorous gas release. The pale yellow mixture was stirred at 0 °C for 30 min and then 
at room temperature for 10 min. TBAI (0.158 g, 0.429 mmol, 5 mol %) was then added, 
immediately followed by benzyl bromide (0.87 mL, 7.3 mmol, 0.85 equiv.). Stirring was then 
continued at room temperature for 4 h. The reaction was therefore quenched by cautious addition 
of water, followed by sat. aq. NH4Cl. The aqueous layer was then extracted with EtAOc (3 x 25 
mL). The combined extracts were washed with water, brine, dried over MgSO4, filtered and 
concentrated in vacuo to afford a pale yellow crude oil. The latter was purified through column 
chromatography (SiO2; pentane/EtAOc 4/1) to afford 2-((benzyloxy)methyl)prop-2-en-1-ol 47 
(1.53 g, 5.02 mmol, 58% yield) as a colorless oil.
 1
H NMR (400 MHz, CDCl3) δ 7.39 – 7.27 (m, 
5H, ArH), 5.21 (d, J = 1.6 Hz, 1H, C=CH2), 5.16 (d, J = 1.2 Hz, 1H, C=CH2), 4.53 (s, 2H, 
OCH2Ph), 4.20 (m, 2H, OCH2C=C), 4.10 (d, J = 1.1 Hz, 2H, OCH2C=C). NMR data correspond 
to the reported values.
[26]
 Following a reported procedure,
[27]
 2-((benzyloxy)methyl)prop-2-en-1-
ol 47 (0.890 g, 4.99 mmol, 1.0 equiv.) was dissolved in dry Et2O (25 mL). The resulting solution 
was cooled down to 0 °C (ice-water bath) and phosphorus tribromide (0.56 mL, 6.0 mmol, 1.2 
equiv.) was added dropwise. The reaction mixture was allowed to warm to room temperature and 
stirred for 3 h. The reaction was quenched through cautious, dropwise addition of water 
(exothermy!!). The aqueous layer was then extracted with ether (3 x 25 mL). The combined 
organic extracts were washed with brine, dried over MgSO4, filtered and concentrated in vacuo. 
The resulting crude oil was submitted to column chromatography (SiO2; pentane/Et2O 80/20) to 
afford (((2-(bromomethyl)allyl)oxy)methyl)benzene 48 (0.574 g, 2.38 mmol, 48% yield) as a pale 
yellow oil. 
1
H NMR (400 MHz, CDCl3) δ 7.40 – 7.33 (m, 4H, ArH), 7.31 (m, 1H, ArH), 5.36 (d, 
J = 0.9 Hz, 1H, C=CH2), 5.27 (d, J = 1.4 Hz, 1H, C=CH2), 4.54 (s, 2H, CH2), 4.16 (d, J = 1.2 Hz, 
2H, CH2), 4.05 (d, J = 0.8 Hz, 2H, CH2). NMR data correspond to the reported values.
[28]
 
Following a reported procedure,
[10]
 In a 25 mL two-necked round-bottomed flask, methyl 2-
iodobenzoate 13 (0.23 mL, 1.5 mmol, 1.0 equiv.) was dissolved in dry THF (3.0 mL) and the 
solution was cooled to -40 °C (acetonitrile/dry ice bath). isoPropyl magnesium chloride (2.0 M in 
THF; 1.0 mL, 2.0 mmol, 1.35 equiv.) was added dropwise, resulting in the formation of a bright 
yellow suspension, which was stirred at the same temperature for 1 h. A freshly prepared solution 
of CuCN (0.133 g, 1.48 mmol, 1.0 equiv.) and LiCl (0.126 g, 2.97 mmol, 2.0 equiv.) in dry THF 
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(3.0 m) was then added dropwise and the resulting mixture was stirred at -40 °C for additional 40 
min. A solution of (((2-(bromomethyl)allyl)oxy)methyl)benzene 48 (0.555 g, 2.30 mmol, 1.55 
equiv.) in dry THF (0.50 mL) was finally added dropwise at -40 °C. The mixture converted at 
this point into a green-brownish suspension, which was stirred overnight while allowing it to 
warm to room temperature. The reaction was then quenched by pouring the mixture onto a 
mixture of ice and sat. aq. NH4Cl. Upon separation from the organic layer, the aqueous layer was 
extracted with EtOAc (3 x 10 mL). The combined organic extracts were washed with brine, dried 
over MgSO4, filtered and concentrated in vacuo to provide a pale yellow crude oil. The latter was 
then submitted to column chromatography (SiO2; pentane/EtOAc 24/1 to 10/1) to afford methyl 
2-(2-((benzyloxy)methyl)allyl)benzoate 49 (0.440 g, 1.48 mmol, 70% yield) Rf 0.85 
(pentane/EtOAc 5/1)  as a colorless oil. The latter (0.245 g, 0.105 mmol, 1.0 equiv.) was 
dissolved in MeOH (2.2 mL). The solution was cooled to 0 °C and a solution of KOH (0.30 g, 5.3 
mmol, 5.0 equiv.) in water (0.4 mL) was slowly added. The cooling bath was removed and 
stirring was continued at room temperature for 2 h. During this time, the initial suspension 
converted into a pale yellow clear solution. Most of MeOH was then removed under reduced 
pressure. The resulting aqueous mixture was diluted with aq. NaOH (1.0 M) and extracted with 
ether (3 x 10 mL). It was then acidified with concentrated aq. HCl until pH < 3 and extracted with 
DCM (3 x 10 mL). The combined organic extracts were washed with brine, dried MgSO4, 
concentrated in vacuo to provide pure 2-(2-((benzyloxy)methyl)allyl)benzoic acid 1v (0.267 g, 
0.946 mmol, 91% yield) as a crystalline solid. 
1
H NMR (400 MHz, CDCl3) δ 12.03 (br s, 1H, 
CO2H), 8.03 (dd, J = 7.8, 1.6 Hz, 1H, ArH), 7.49 (td, J = 7.5, 1.5 Hz, 1H, ArH), 7.41 - 7.26 (m, 
7H, ArH), 5.12 (q, J = 1.4 Hz, 1H, C=CH2), 4.68 (d, J = 1.7 Hz, 1H, C=CH2), 4.51 (s, 2H, 
PhCH2O), 4.01 (s, 2H, C=CCH2O), 3.86 (s, 2H, ArCH2). 
13
C NMR (101 MHz, CDCl3) δ 173.0, 
145.5, 141.4, 138.2, 132.7, 131.9, 131.6, 129.0, 128.3, 127.7, 127.5, 126.4, 113.2, 73.2, 71.9, 
37.6. IR 3065 (m), 3030 (m), 2911 (w), 2858 (m), 2718 (w), 2717 (w), 2657 (w), 2560 (w), 1774 
(w), 1691 (s), 1654 (w), 1602 (w), 1576 (w), 1495 (w), 1455 (w), 1407 (w), 1365 (w), 1351 (w), 
1302 (m), 1272 (m), 1167 (w), 1138 (w), 1094 (m), 1075 (m), 1029 (w), 909 (m). HRMS (ESI) 
calcd for C18H17O3
-
 [M+H-1]
-
 281.1183; found 281.1187.  Melting Point: 78.5-80.3 °C. 
 
2-(1-(4-Chlororophenyl)vinyl)benzoic acid (1w) 
 
According to the general procedure, starting from 2-(4-chlorobenzoyl)benzoic acid (2.81 g, 10.8 
mmol, 1.0 equiv.), tBuOK (3.14 g, 28.0 mmol, 2.6 equiv.) and 
bromo(methyl)triphenylphosphorane (5.00 g, 14.0 mmol, 1.3 equiv.), the product was obtained as 
a white solid 2 (1.3 g, 5.03 mmol, 47 % yield). 
1
H NMR (400 MHz, CDCl3) δ 7.95 (dd, J = 7.8, 
1.4 Hz, 1H), 7.58 (td, J = 7.5, 1.4 Hz, 1H), 7.44 (td, J = 7.6, 1.3 Hz, 1H), 7.35 (dd, J = 7.6, 1.3 
Hz, 1H), 7.23 – 7.18 (m, 2H), 7.16 – 7.11 (m, 2H), 5.65 (d, J = 0.9 Hz, 1H, C=CH2), 5.23 (d, J = 
0.9 Hz, 1H, C=CH2). 
13
C NMR (101 MHz, CDCl3) δ 172.0, 148.5, 143.2, 139.4, 133.3, 132.7, 
131.5, 130.9, 129.1, 128.2, 128.0, 127.9, 114.7. NMR data correspond to the reported values.
[13]
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4. Photoredox Catalysis 
 General procedure for the photoredox catalysis. a.
 
Dry acetonitrile (1.0 mL) degassed by bubbling nitrogen for 5 min, was added in a flame dried 4 
mL test tube containing a teflon coated stirring bar, the enoic acid 1 (0.20 mmol, 1.0 equiv), ABX 
reagent 3a (116 mg, 0.400 mmol, 2.0 equiv) and Cu[dap]2Cl (0.8 mg, 0.9 µmol, 0.5 mol%). The 
resulting solution was irradiated under stirring using blue light LEDs for 18 h at rt. The reaction 
mixture was filtered, eluting with ethyl acetate, and evaporated under reduced pressure. The 
residue was purified by flash SiO2 column (Pentane/EtOAc : 100 to 90/10 to 80/20) to give the 
corresponding azidolactone product 2. (The flash SiO2 column has to be deactivated by flashing 
mixture of pentane/Et3N (95/5) before flashing 100% pentane). 
 
5-(Azidomethyl)-5-phenyldihydrofuran-2(3H)-one (2a) 
 
Starting from 4-phenylpent-4-enoic acid 1a (35 mg, 0.20 mmol, 1.0 equiv.), the crude product 
was purified by column chromatography (Pentane/EtOAc = 9:1 to 8/2) to afford 2a as yellow 
solid (35 mg, 0.16 mmol, 81 % yield). Rf: 0.45 (Pentane/Ethyl Acetate = 8:2) (Seebach Stain). 
1
H 
NMR (400 MHz, CDCl3) δ 7.44 – 7.32 (m, 5H, ArH), 3.68 (d, J = 13.2 Hz, 1H, CH2N3), 3.53 (d, 
J = 13.2 Hz, 1H, CH2N3), 2.81 – 2.64 (m, 2H, CH2CH2), 2.57 – 2.38 (m, 2H, CH2CH). 
13
C NMR 
(101 MHz, CDCl3) δ 175.7, 140.6, 129.0, 128.6, 124.8, 87.7, 60.0, 31.5, 28.8. NMR data 
correspond to the reported values.
 [18]
 
 
5-(Azidomethyl)-5-(p-tolyl)dihydrofuran-2(3H)-one (2b) 
 
Starting from 4-(p-tolyl)pent-4-enoic acid 1b (38 mg, 0.20 mmol, 1.0 equiv.), the crude product 
was purified by column chromatography (Pentane/EtOAc = 9:1 to 8/2) to afford 2b as pale 
yellow oil (38 mg, 0.16 mmol, 82 % yield). Rf: 0.40 (Pentane/Ethyl Acetate = 8:2) (Seebach 
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Stain).
1
H NMR (400 MHz, CDCl3) δ 7.27 (d, J = 8.2 Hz, 2H, ArH), 7.22 (d, J = 8.1 Hz, 2H, 
ArH), 3.67 (d, J = 13.2 Hz, 1H, CH2N3), 3.52 (d, J = 13.1 Hz, 1H, CH2N3), 2.80 – 2.62 (m, 2H, 
CH2CH2), 2.59 – 2.39 (m, 2H, CH2CH2), 2.36 (s, 3H, CH3). 
13
C NMR (101 MHz, CDCl3) δ 
176.0, 138.5, 137.5, 129.6, 124.7, 87.8, 60.0, 31.4, 28.8, 21.1. IR ν 3063 (w), 3030 (w), 2923 
(w), 2105 (s), 1779 (s), 1516 (w), 1280 (m), 1075 (m), 937 (m). HRMS (ESI) calcd for 
C12H13N3NaO2
+
 [M+Na]
+
 254.0900; found 254.0903.  
 
5-(Azidomethyl)-5-(4-methoxyphenyl)dihydrofuran-2(3H)-one (2c) 
 
Starting from 4-(4-methoxyphenyl)pent-4-enoic acid 1c (41 mg, 0.20 mmol, 1.0 equiv.), the 
crude product was purified by column chromatography (Pentane/EtOAc = 9:1 to 8/2) to afford 2c 
as white solid (43 mg, 0.17 mmol, 87 % yield). Rf: 0.60 (Pentane/Ethyl Acetate = 7:3) (Seebach 
Stain). 
1
H NMR (400 MHz, CDCl3) δ 7.30 (d, J = 8.5 Hz, 2H, ArH), 6.92 (d, J = 8.5 Hz, 2H, 
ArH), 3.81 (s, 3H, OCH3), 3.66 (d, J = 13.1 Hz, 1H, CH2N3), 3.48 (d, J = 13.1 Hz, 1H, CH2N3), 
2.80 – 2.61 (m, 2H, CH2CH2), 2.57 – 2.36 (m, 2H, CH2CH2). 
13
C NMR (101 MHz, CDCl3) δ 
175.8, 159.8, 132.5, 126.2, 114.3, 87.6, 60.2, 55.5, 31.4, 28.9. NMR data correspond to the 
reported values.
[18]
 
 
5-(Azidomethyl)-5-(4-bromophenyl)dihydrofuran-2(3H)-one (2d) 
 
Starting from 4-(4-bromophenyl)pent-4-enoic acid 1d (51 g, 0.20 mmol, 1.0 equiv.), the crude 
product was purified by column chromatography (Pentane/EtOAc = 9:1 to 8/2) to afford 2d as 
pale yellow oil (46 mg, 0.15 mmol, 78 % yield). Rf: 0.43 (Pentane/ EtOAc = 8:2) (Seebach 
Stain). 
1
H NMR (400 MHz, CDCl3) δ 7.62 – 7.52 (m, 2H, ArH), 7.29 – 7.21 (m, 2H, ArH), 3.66 
(d, J = 13.2 Hz, 1H, CH2N3), 3.52 (d, J = 13.2 Hz, 1H, CH2N3), 2.84 – 2.64 (m, 2H, CH2CH2), 
2.53 (m, 1H, CH2CH2), 2.40 (m, 1H, CH2CH2). 
13
C NMR (101 MHz, CDCl3d) δ 175.4, 139.7, 
132.1, 126.6, 122.8, 87.2, 59.8, 31.4, 28.7.NMR data correspond to the reported values.
[18]
 
 
5-(Azidomethyl)-5-(4-fluorophenyl)dihydrofuran-2(3H)-one (2e) 
 
Starting from 4-(4-fluorophenyl)pent-4-enoic acid 1e  (39 mg, 0.20 mmol, 1.0 equiv.), the crude 
product was purified by column chromatography (Pentane/EtOAc = 9:1 to 8/2) to afford 2e as 
pale yellow solid (35 mg, 0.15 mmol, 74 % yield). Rf: 0.5 (Pentane/ EtOAc = 7:3) (Seebach 
Stain). 
1
H NMR (400 MHz, CDCl3) δ 7.40 – 7.33 (m, 2H, ArH), 7.13 – 7.05 (m, 2H, ArH), 3.65 
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(d, J = 13.0 Hz, 1H, CH2N3), 3.51 (d, J = 13.2, 1H, CH2N3), 2.83 – 2.62 (m, 2H, CH2CH2), 2.57 – 
2.48 (m, 1H, CH2CH2), 2.45 – 2.36 (m, 1H, CH2CH2). 
13
C NMR (101 MHz, CDCl3) δ 175.6, 
162.7 (d, J = 248.0 Hz), 136.4 (d, J = 3.2 Hz), 126.8 (d, J = 8.2 Hz), 115.9 (d, J = 21.7 Hz), 87.3, 
60.0, 31.5, 28.7. 
19
F NMR (376 MHz, CDCl3) δ -113.14 (m, 1F). IR 3078 (w), 3078 (w), 3078 
(w), 2972 (w), 2932 (w), 2106 (s), 1783 (s), 1605 (w), 1512 (s), 1285 (m), 1232 (m). HRMS 
(ESI) calcd for C11H10FN3NaO2
+
 [M+Na]
+
 258.0649; found 258.0650. Melting point: 71 °C. 
 
Gram scale synthesis:  
Starting from 4-(4-fluorophenyl)pent-4-enoic acid 1e (1.00 g, 5.15 mmol, 1.0 equiv.), ABX 3a 
(2.98 g, 10.30 mmol, 2.0 equiv.) and Cu[dap]2Cl (2.3 mg, 2.50 µmol, 0.05 mol%). The crude 
product was purified by column chromatography (Pentane/EtOAc = 9:1 to 8/2) to afford 2e as 
pale yellow solid (990 mg, 4.21 mmol, 82 % yield). (The flash SiO2 column has to be deactivated 
by flashing mixture of pentane/Et3N (95/5) before flashing 100% pentane). 
 
5-(Azidomethyl)-5-(4-chlorophenyl)dihydrofuran-2(3H)-one (2f) 
 
Starting from 4-(4-chlorophenyl)pent-4-enoic acid 1f (42 mg, 0.20 mmol, 1.0 equiv.), the crude 
product was purified by column chromatography (Pentane/EtOAc = 9:1 to 8/2) to afford 2f as 
pale yellow solid (34 mg, 0.13 mmol, 68 % yield). Rf: 0.45 (Pentane/ EtOAc = 7:3) (Seebach 
Stain). 
1
H NMR (400 MHz, CDCl3) δ 7.38 (d, J = 8.4 Hz, 2H, ArH), 7.32 (d, J = 8.6 Hz, 2H, 
ArH), 3.65 (d, J = 13.1, 1H, CH2N3), 3.51 (d, J = 13.2, 1H, CH2N3), 2.83 – 2.62 (m, 2H, 
CH2CH2), 2.52 (m, 1H, CH2CH2), 2.39 (m, 1H, CH2CH2). 
13
C NMR (101 MHz, CDCl3) δ 175.4, 
139.1, 134.7, 129.2, 126.3, 87.2, 60.0, 31.5, 28.7. NMR data correspond to the reported values.
[18]
 
 
3-(Azidomethyl)-3-methylisobenzofuran-1(3H)-one (2g) 
 
Starting from 2-(prop-1-en-2-yl)benzoic acid 1g (32 mg, 0.20 mmol, 1.0 equiv.), the crude 
product was purified by column chromatography (Pentane/EtOAc = 9:1 to 8/2) to afford 2g as 
white solid (38 mg, 0.19 mmol, 94 % yield). Rf: 0.55 (Pentane/ EtOAc = 8:2) (Seebach Stain). 
1
H NMR (400 MHz, CDCl3) δ 7.91 (d, J = 7.6 Hz, 1H, ArH), 7.70 (t, J = 7.5 Hz, 1H, ArH), 7.57 
(t, J = 7.5 Hz, 1H, ArH), 7.45 (d, J = 7.7 Hz, 1H, ArH), 3.65 (m, 2H, CH2N3), 1.69 (s, 3H, CH3). 
13
C NMR (101 MHz, CDCl3) δ 169.1, 150.8, 134.5, 129.8, 126.1, 126.1, 121.3, 85.8, 58.1, 23.2. 
IR 3055 (w), 2985 (w), 2933 (w), 2105 (s), 1761 (s), 1468 (w), 1288 (m), 1035 (s). HRMS (ESI) 
calcd for C10H9N3NaO2
+
 [M+Na]
+
 226.0587; found 226.0588. Melting point : 77 °C 
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3-(Azidomethyl)-3-phenylisobenzofuran-1(3H)-one (1h) 
 
Starting from 2-(1-phenylvinyl)benzoic acid 1h (50 mg, 0.20 mmol, 1.0 equiv.), the crude 
product was purified by column chromatography (Pentane/EtOAc = 9:1 to 8/2) to afford 2h as 
white solid (49 mg, 0.19 mmol, 92 % yield). Rf: 0.8 (Pentane/ EtOAc = 7:3) (Seebach Stain). 
1
H 
NMR (400 MHz, CDCl3) δ 7.96 (d, J = 7.6 Hz, 1H, ArH), 7.73 (t, J = 7.5 Hz, 1H, ArH), 7.61 (m, 
2H, ArH), 7.53 (m, 2H, ArH), 7.39 (m, 3H, ArH), 4.07 (d, J = 13.1 Hz, 1H, CH2N3), 3.99 (d, J = 
13.1 Hz, 1H, CH2N3). 
13
C NMR (101 MHz, CDCl3) δ 169.2, 149.6, 137.3, 134.7, 130.2, 129.3, 
129.23, 126.4, 126.3, 125.5, 122.9, 88.7, 58.3. IR 3069 (w), 2925 (w), 2854 (w), 2102 (s), 1773 
(s), 1600 (w), 1467 (m), 1288 (m), 1103 (m), 1017 (m). HRMS (ESI) calcd for C15H11N3NaO2
+
 
[M+Na]
+
 288.0743; found 288.0741. Melting point : 90 °C. 
 
3-(Azidomethyl)-3-(4-fluorophenyl)isobenzofuran-1(3H)-one (2i) 
 
Starting from 2-(1-(4-fluorophenyl)vinyl)benzoic acid 1i (48 mg, 0.20 mmol, 1.0 equiv.), the 
crude product was purified by column chromatography (Pentane/EtOAc = 9:1 to 8/2) to afford 2i 
as yellow oil (51 mg, 0.18 mmol, 91 % yield). Rf: 0.55 (Pentane/ EtOAc = 8:2) (Seebach Stain). 
1
H NMR (400 MHz, CDCl3) δ 7.98 (m, 1H, ArH), 7.75 (td, J = 7.5, 1.1 Hz, 1H, ArH), 7.62 (m, 
2H, ArH), 7.53(m, 2H, ArH), 7.09 (m, 2H, ArH), 4.03 (d, J = 13.1 Hz, 1H, CH2N3), 3.96 (d, J = 
13.1 Hz, 1H, CH2N3). 
13
C NMR (101 MHz, CDCl3) δ 169.0, 163.1 (d, J = 249.2 Hz), 149.4, 
134.8, 133.2 (d, J = 3.3 Hz), 130.3, 127.7 (d, J = 8.4 Hz), 126.6, 126.3, 122.8, 116.2 (d, J = 21.7 
Hz), 88.1, 58.3. 
19
F NMR (376 MHz, CDCl3) δ -112.12 (m, 1F). IR 3079 (w), 2930 (w), 2104 
(s), 1770 (s), 1599 (w), 1512 (m), 1289 (m), 1242 (m). HRMS (ESI) calcd for C15H10FN3NaO2
+
 
[M+Na]
+
 306.0649; found 306.0648 
 
5-(Azidomethyl)-3,3-dimethyl-5-phenyldihydrofuran-2(3H)-one (2j) 
 
Starting from 2,2-dimethyl-4-phenylpent-4-enoic acid 1j (41 mg, 0.20 mmol, 1.0 equiv.), the 
crude product was purified by column chromatography (Pentane/EtOAc = 9:1 to 8/2) to afford 2j 
as brown oil (44 mg, 0.17 mmol, 90 % yield). Rf: 0.55 (Pentane/ EtOAc = 8:2) (Seebach Stain). 
1
H NMR (400 MHz, CDCl3) δ 7.44 – 7.30 (m, 5H, ArH), 3.62 (d, J = 13.1 Hz, 1H, CH2N3), 3.40 
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(d, J = 13.2 Hz, 1H, CH2N3), 2.61 (d, J = 13.0 Hz, 1H, C(CH3)2CH2), 2.41 (d, J = 13.0 Hz, 1H, 
C(CH3)2CH2), 1.36 (s, 3H, CH3), 0.98 (s, 3H, CH3). 
13
C NMR (101 MHz, CDCl3) δ 181.0, 141.5, 
129.0, 128.5, 124.7, 84.6, 60.2, 45.3, 40.6, 26.5, 26.0. IR 3065 (w), 2975 (w), 2933 (w), 2874 
(w), 2103 (s), 1772 (s), 1450 (m), 1253 (m), 1157 (m), 1053 (s). HRMS (ESI) calcd for 
C13H15N3NaO2
+
 [M+Na]
+
 268.1056; found 268.1056. 
 
5-(Azidomethyl)-5-(thiophen-3-yl)dihydrofuran-2(3H)-one (2k) 
 
Starting from 4-(thiophen-3-yl)pent-4-enoic acid 1k  (25 mg, 0.12 mmol, 1.0 equiv.), ABX 3a (70 
mg, 0.24 mmol, 2.0 equiv.) and Cu[dap]2Cl (0.5 mg, 0.6 µmol, 0.5 mol%), the crude product was 
purified by column chromatography (Pentane/EtOAc = 9:1 to 8/2) to afford 2k as pale yellow oil 
(22 mg, 0.10 mmol, 81 % yield). Rf: 0.45 (Pentane/ EtOAc = 7:3) (Seebach Stain). 
1
H NMR 
(400 MHz, CDCl3) δ 7.39 (m, 1H, ArH), 7.31 (m, 1H, ArH), 7.00 (m, 1H, ArH), 3.71 (d, J = 13.1 
Hz, 1H, CH2N3), 3.53 (d, J = 13.1 Hz, 1H, CH2N3), 2.78 – 2.51 (m, 3H, CH2CH2), 2.40 (m, 1H, 
CH2CH2). 
13
C NMR (101 MHz, CDCl3d) δ 175.7, 141.7, 127.6, 124.7, 121.9, 86.4, 59.2, 31.2, 
28.8. NMR data correspond to the reported values.
 [18]
 
 
5-(Azidomethyl)-5-(2,5-dimethylphenyl)dihydrofuran-2(3H)-one (2l) 
 
Starting from 4-(2,5-dimethylphenyl)pent-4-enoic acid 1l (41 mg, 0.20 mmol, 1.0 equiv.), the 
crude product was purified by column chromatography (Pentane/EtOAc = 9:1 to 8/2) to afford 2l 
as pale yellow solid (35 mg, 0.14 mmol, 71 % yield). Rf: 0.48 (Pentane/ EtOAc = 8:2) (Seebach 
Stain). Two rotamers are observed in NMR analysis, however they are not fully resolved. Only 
the major rotamer is described. 
1
H NMR (400 MHz, CDCl3) δ 7.40 – 7.33 (m, 1H, ArH), 7.11 – 
6.99 (m, 2H, ArH), 3.67 (s, 2H, CH2N3), 2.86 – 2.69 (m, 2H, CH2CH2), 2.61 – 2.44 (m, 2H, 
CH2CH2), 2.37 (m, 3H, CH3), 2.32 (m, 3H, CH3). 
13
C NMR (101 MHz, CDCl3) δ 175.8, 138.3, 
136.2, 132.7, 130.4, 129.3, 126.5, 88.8, 58.9, 31.3, 29.0, 21.2, 21.1. IR 3027 (w), 2955 (w), 2359 
(w), 2108 (s), 1783 (s), 1299 (w), 1190 (m). HRMS (ESI) calcd for C13H15N3NaO2
+
 [M+Na]
+
 
268.1056; found 268.1064. Melting point : 61 °C. 
 
8b-(Azidomethyl)-3,3a,4,8b-tetrahydro-2H-indeno[1,2-b]furan-2-one (2m) 
 
Starting from 2-(1-methylene-2,3-dihydro-1H-inden-2-yl)acetic acid 1m (38 mg, 0.20 mmol, 1.0 
equiv.), the crude product was purified by column chromatography (Pentane/EtOAc = 9:1 to 8/2) 
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to afford 2m as pale yellow oil (30 mg, 0.13 mmol, 65 % yield). Rf: 0.5 (Pentane/ EtOAc = 7:3) 
(Seebach Stain). 
1
H NMR (400 MHz, CDCl3) δ 7.44 – 7.36 (m, 2H, ArH), 7.34 – 7.24 (m, 2H, 
ArH), 3.96 (d, J = 13.1 Hz, 1H, CH2N3), 3.52 (d, J = 13.1 Hz, 1H, CH2N3), 3.34 (dd, J = 16.5, 8.3 
Hz, 1H, ArCH2CH), 3.27 – 3.17 (m, 1H, CH), 3.05 (dd, J = 18.2, 10.0 Hz, 1H, OCOCH2CH), 
2.86 (dd, J = 16.6, 2.9 Hz, 1H, ArCH2CH), 2.40 (dd, J = 18.2, 6.3 Hz, 1H, OCOCH2CH). 
13
C 
NMR (101 MHz, CDCl3) δ 175.7, 142.2, 138.9, 130.7, 128.0, 125.8, 124.8, 96.0, 56.2, 40.3, 
37.4, 37.0. IR 3073 (w), 3030 (w), 2939 (w), 2860 (w), 2255 (w), 2108 (s), 1780 (s), 1194 (m), 
956 (m), 911 (s).  HRMS (ESI) calcd for C12H11N3NaO2
+
 [M+Na]
+
 252.0743; found 252.0748.  
 
5-(Azidomethyl)-5-(phenylethynyl)dihydrofuran-2(3H)-one (2n) 
 
Starting from 4-methylene-6-phenylhex-5-ynoic acid 1n (40 mg, 0.20 mmol, 1.0 equiv.), the 
crude product was purified by column chromatography (Pentane/EtOAc = 9:1 to 8/2) to afford 2n 
as pale yellow oil (23 mg, 0.095 mmol, 47 % yield). Rf: 0.70 (Pentane/ EtOAc = 7:3) (Seebach 
Stain). 
1
H NMR (400 MHz, CDCl3) δ 7.50 – 7.42 (m, 2H, ArH), 7.40 – 7.30 (m, 3H, ArH), 3.77 
(d, J = 13.0, 1H, CH2N3), 3.61 (d, J = 13.0, 1H, CH2N3), 2.89 – 2.78 (m, 1H, CH2CH2), 2.75 – 
2.65 (m, 1H, CH2CH2), 2.59 – 2.48 (m, 2H, CH2CH2). 
13
C NMR (101 MHz, CDCl3) δ 175.27, 
132.0, 129.5, 128.6, 121.1, 88.1, 85.3, 80.0, 57.9, 32.3, 28.8. NMR data correspond to the 
reported values.
[18]
 
 
6-(Azidomethyl)-6-phenyltetrahydro-2H-pyran-2-one (2o) 
 
Starting from 5-phenylhex-5-enoic acid 1o (38 mg, 0.20 mmol, 1.0 equiv.), the crude product was 
purified by column chromatography (Pentane/EtOAc = 9:1 to 8/2) to afford 2o as pale yellow oil 
(15 mg, 0.065 mmol, 33 % yield). Rf: 0.8 (Pentane/ EtOAc = 7:3) (Seebach Stain). 
1
H NMR 
(400 MHz, CDCl3) δ 7.45 – 7.31 (m, 5H, ArH), 3.61 (d, J = 13.0 Hz, 1H, CH2N3), 3.42 (d, J = 
13.0 Hz, 1H, CH2N3), 2.50 (m, 2H, CH2), 2.25 (m, 2H, CH2), 1.83 (m, 1H, CH2), 1.60 (m, 1H, 
CH2). 
13
C NMR (101 MHz, CDCl3) δ 170.1, 140.4, 129.2, 128.5, 125.3, 86.9, 60.8, 29.3, 29.1, 
16.2. NMR data correspond to the reported values.
[18]
 
 
6-(Azidomethyl)-4,4-dimethyl-6-phenyltetrahydro-2H-pyran-2-one (2p) 
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Starting from 3,3-dimethyl-5-phenylhex-5-enoic acid 1p (44 mg, 0.20 mmol, 1.0 equiv.), the 
crude product was purified by column chromatography (Pentane/EtOAc = 9:1 to 8/2) to afford 2p 
as colorless oil (21 mg, 0.081 mmol, 42 % yield). Rf: 0.43 (Pentane/ EtOAc = 8:2) (Seebach 
Stain). 
1
H NMR (400 MHz, CDCl3) δ 7.45 – 7.28 (m, 5H, ArH), 3.50 (d, J = 12.9, 1H, CH2N3), 
3.29 (d, J = 12.9 Hz, 1H, CH2N3), 2.35 – 2.16 (m, 4H, CH2), 1.10 (s, 3H, CH3), 0.78 (s, 3H CH3). 
13
C NMR (101 MHz, CDCl3) δ 171.1, 141.6, 129.0, 128.3, 125.1, 85.8, 62.0, 43.8, 41.7, 31.9, 
30.7, 29.1. NMR data correspond to the reported values.
[18]
 
 
6-(Azidomethyl)-6-phenyl-1,4-dioxan-2-one (2q) 
 
Starting from 2-((2-phenylallyl)oxy)acetic acid 1q (38 mg, 0.20 mmol, 1.0 equiv.), the crude 
product was purified by column chromatography (Pentane/EtOAc = 9:1 to 8/2) to afford 2q as 
pale yellow oil (25 mg, 0.11 mmol, 54 % yield). Rf: 0.42 (Pentane/ EtOAc = 8:2) (Seebach 
Stain). 
1
H NMR (400 MHz, CDCl3) δ 7.47 – 7.36 (m, 5H, ArH), 4.44 (d, J = 17.7 Hz, 1H, 
CO2CH2O), 4.28 (d, J = 17.9 Hz, 1H, CO2CH2O), 4.24 (d, J = 12.7 Hz, 1H, CCH2O), 4.03 (d, J = 
12.7 Hz, 1H, CCH2O), 3.78 (d, J = 13.0 Hz, 1H, CH2N3), 3.67 (d, J = 13.0 Hz, 1H, CH2N3). 
13
C 
NMR (101 MHz, CDCl3) δ 166.2, 137.5, 129.2, 129.1, 125.1, 84.6, 67.9, 65.7, 57.3. IR 3065 
(w), 2875 (w), 2109 (s), 1762 (s), 1451 (w), 1262 (s), 1129 (m), 954 (w), 908 (m). HRMS (ESI) 
calcd for C11H11N3NaO3
+
 [M+Na]+ 256.0693; found 256.0690. 
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5. Optimization for the Lewis-acid catalyzed cascade 
functionalization of alkenes 
 
Dry acetonitrile (0.5 mL) was added in a flame dried 4 mL test tube containing a teflon coated 
stirring bar, the enoic acid 1 (0.10 mmol, 1.0 equiv), ADBX reagent 3b (45 mg, 0.15 mmol, 1.5 
equiv) and the catalyst. The resulting solution was stirred under N2 at room temperature for 
mentioned time. After completion of the reaction, the crude mixture was obtained after 
concentration under reduced pressure. Then addition of 6 L of CH2Br2 as internal standard gave 
NMR yield.. 
 
Entry Catalyst (10 mol%) Time Concentration (M) Conversion
[a] 
(%) Yield
[b] 
(%) 
1
[c]
 Pd(OAc)2 15 h 0.040 90 34 
2
[c]
 Pd(TFA)2 15 h 0.040 90 32 
3
[c]
 Pd(OPiv)2 15 h 0.040 90 32 
4 AgBF4 15 h 0.040 >95 5 
5 Pd(OAc)2 15 h 0.040 >95 53 
6 Pd(acac)2 15 h 0.040 25 48 
7 Pd(tfacac)2 15 h 0.040 >95 47 
8 Pd(hfacac)2 15 h 0.040 >95 60 
9
[d]
 Pd(hfacac)2 15 h 0.040 >95 10 
10 Pd(hfacac)2 15 h 0.20 >95 63 
11 Pd(hfacac)2 15 h 0.40 >95 59 
12 Pd(hfacac)2 5 h 1.0 >95 60 
13
[e]
 Pd(hfacac)2 5 h 0.20 >95 57 
14
[f]
 Pd(hfacac)2 5 h 0.20 >95 54 
15
[g]
 Pd(hfacac)2 1 h 0.20 >95 60 
16 In(OTf)3 2 h 0.20 Low 45 
17 Sn(OTf)2 2 h 0.20 >95 85 
18 Zn(OTf)2 2 h  0.20 >95 58 
19 Zn(NTf2)2 2 h 0.20 >95 <5 
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20 Zn(BF4)2,H2O 2 h  0.20 >95 <10 
21 Sc(OTf)3 2 h  0.20 >95 35 
22
[h]
 Sn(OTf)2 2 h 0.20 >95 16 
23
[i]
 Sn(OTf)2 2 h 0.20 >95 75 
24
[g,i]
 Sn(OTf)2 2 h 0.20 >95 80
[k]
 
25
[h]
 Pd(hfacac)2 2 h  0.20 >95 58 
26
[j]
 Pd(hfacac)2 2 h 0.20 >95 75 
[a]
 The conversion of 5a by NMR is given. The reaction is stirred at RT unless otherwise noted. 
[b] 
NMR yield after 
using 6 L CH2Br2 as internal standard. 
[c]
 In DCM 
[d] 
Using 1.5 equiv of ABX reagent. 
[e]
 At 50 °C. [f] At 0 °C. 
[g] 
Using 2.0 equiv of ADBX reagent. 
[h]
 20 mol% catalyst 
[i]
 5 mol% catalyst 
[j]
 2 mol% catalyst [k] Issue of reproducibility 
using Sn(OTf)2 as catalyst. Reactions were performed several times yielding always very different outcomes, ranging from about 
20 to 80% NMR yield. 
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6. Lewis acid catalyzed azidolactonization. 
General Procedure 
 
Dry acetonitrile (1.5 mL) was added in a flame dried 4 mL test tube containing a teflon coated 
stirring bar, the enoic acid 1 (0.30 mmol, 1.0 equiv), ADBX reagent 3b (136 mg, 0.450 mmol, 
1.5 equiv) and Pd(hfacac)2 (3.1 mg, 6.0 mol, 0.02 equiv.). The resulting solution was stirred 
under N2 at room temperature for 2 h unless otherwise noted. After completion of the reaction, 
the crude mixture was obtained after concentration under reduced pressure. Then addition of 18 
L of CH2Br2 as internal standard gave NMR yield. Final purification was performed by column 
chromatography (Pentane/EtOAc : 100 to 90/10 to 80/20) over silica gel affording the 
corresponding azidolactone product 4. 
 
5-Azido-5-benzyldihydrofuran-2(3H)-one (4a) 
 
Starting from 1a (53 mg, 0.30 mmol), the crude product (75% NMR yield) was purified by 
column chromatography (Pentane/Ethyl Acetate = 9:1 then 8:2) to afford 4a as colorless oil (34 
mg, 0.16 mmol, 52%). 
1
H NMR (400 MHz, CDCl3) δ 7.44 – 7.26 (m, 5H, ArH), 3.34 (d, J = 14.1 
Hz, 1H, ArCH2), 3.23 (d, J = 14.1 Hz, 1H, ArCH2), 2.74 – 2.55 (m, 1H, O2CCH2CH2), 2.31 – 
2.22 (m, 1H, O2CCH2CH2), 2.23 – 2.16 (m, 1H, O2CCH2CH2), 2.11 – 1.94 (m, 1H, 
O2CCH2CH2). 
13
C NMR (101 MHz, CDCl3) δ 174.7, 133.1, 130.4, 128.7, 127.8, 99.4, 43.7, 31.3, 
28.3. IR 3033 (w), 2928 (w), 2858 (w), 2602 (w), 2477 (w), 2118 (s), 1796 (s), 1718 (w), 1490 
(w), 1456 (w), 1424 (w), 1332 (w), 1248 (m), 1167 (m), 1085 (w), 1031 (w), 916 (m), 875 (w). 
HRMS (APPI) calcd for C11H12NO2
+
 [M-N2+H]
+
 190.0863; found 190.0863. 
 
5-Azido-5-(4-bromobenzyl)dihydrofuran-2(3H)-one (4b) 
 
Starting from 4-(4-bromophenyl)pent-4-enoic acid 1d (51 mg, 0.20 mmol, 1.0 equiv.), ADBX 
reagent 3b (92 mg, 0.30 mmol, 1.5 equiv) and Pd(hfacac)2 (2.1 mg, 4.0 mol, 0.02 equiv.), the 
crude product (80% NMR yield) was purified by column chromatography (Pentane/EtOAc = 9:1 
to 8/2) to afford 4b as pale orange oil (31 mg, 0.11 mmol, 53 % yield). Rf: 0.40 (Pentane/ EtOAc 
= 8:2) (KMnO4 Stain). 
1
H NMR (400 MHz, CDCl3) δ 7.47 (m, 2H, ArH), 7.17 (m, 2H, ArH), 
3.29 (d, J = 14.2 Hz, 1H, CH2Ar), 3.18 (d, J = 14.2 Hz, 1H, CH2Ar), 2.68 (dt, J = 17.9, 9.7 Hz, 
1H, O2CCH2CH2), 2.33 (ddd, J = 17.9, 9.4, 3.2 Hz, 1H, O2CCH2CH2), 2.15 (m, 1H, 
O2CCH2CH2), 2.03 (ddd, J = 13.1, 9.5, 3.2 Hz, 1H, O2CCH2CH2). 
13
C NMR (101 MHz, CDCl3) 
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δ 174.7, 132.3, 132.2, 132.0, 122.2, 99.1, 43.3, 31.4, 28.3. IR 2990 (w), 2936 (w), 2116 (s), 1796 
(s), 1493 (m), 1249 (m), 1165 (m), 1017 (m), 911 (s). HRMS (ESI) calcd for C11H1lBrNO2
+
 [M-
N2+H]
+
 267.9973; found 267.9973. 
 
1.5 mmol scale synthesis:  
Starting from 4-(4-bromophenyl)pent-4-enoic acid 1d (400 mg, 1.57 mmol, 1.0 equiv.), ADBX 
3b (713 mg, 2.35 mmol), 1.5 equiv.) and Pd(hfacac)2 (16 mg, 0.031 mmol, 0.02 equiv.). The 
crude product (80% NMR yield) was purified by column chromatography (Pentane/EtOAc = 9:1 
to 8/2) to afford 4b as pale orange oil (280 mg, 0.946 mmol, 60 % yield). 
 
5-Azido-5-(4-fluorobenzyl)dihydrofuran-2(3H)-one (4c) 
 
Starting from 4-(4-fluorophenyl)pent-4-enoic acid 1e (39 mg, 0.20 mmol, 1.0 equiv.), ADBX 
reagent 3b (92 mg, 0.30 mmol, 1.5 equiv) and Pd(hfacac)2 (2.1 mg, 4.0 mol, 0.02 equiv.), the 
crude product (68% NMR yield) was purified by column chromatography (Pentane/EtOAc = 9:1 
to 8/2) to afford 4c as pale yellow oil (22 mg, 0.094 mmol, 46 % yield). Rf: 0.40 (Pentane/ 
EtOAc = 8:2) (KMnO4 Stain). 
1
H NMR (400 MHz, CDCl3) δ 7.29 (m, 2H, ArH), 7.04 (m, 2H, 
ArH), 3.32 (d, J = 14.3 Hz, 1H, CH2Ar), 3.21 (d, J = 14.3 Hz, 1H, CH2Ar), 2.69 (dt, J = 17.8, 9.6 
Hz, 1H, O2CCH2CH2), 2.33 (ddd, J = 17.8, 9.4, 3.1 Hz, 1H, O2CCH2CH2), 2.18 (m, 1H, 
O2CCH2CH2), 2.04 (m, 1H, O2CCH2CH2). 
13
C NMR (101 MHz, CDCl3) δ 174.8, 162.6 (d, J = 
247.0 Hz), 132.2 (d, J = 8.2 Hz), 129.0 (d, J = 3.3 Hz), 115.9 (d, J = 21.4 Hz), 99.3, 43.1, 31.5, 
28.3. 
19
F NMR (376 MHz, CDCl3) δ -114.28 (m, 1F). IR 3048 (w), 2932 (w), 2116 (s), 1796 (s), 
1607 (w), 1513 (s), 1227 (s), 1161 (s), 911 (s). HRMS (ESI) calcd for C11H10FN3NaO2
+
 [M+Na]
+
 
258.0649; found 258.0655 
 
5-Azido-5-(4-chlorobenzyl)dihydrofuran-2(3H)-one (4d) 
 
Starting from 4-(4-chlorophenyl)pent-4-enoic acid 1f (42 mg, 0.20 mmol, 1.0 equiv.), ADBX 
reagent 3b (92 mg, 0.30 mmol, 1.5 equiv) and Pd(hfacac)2 (2.1 mg, 4.0 mol, 0.02 equiv.), the 
crude product (80% NMR yield) was purified by column chromatography (Pentane/EtOAc = 9:1 
to 8/2) to afford 4d as pale yellow oil (32 mg, 0.13 mmol, 63 % yield). Rf: 0.38 (Pentane/ EtOAc 
= 8:2) (KMnO4 Stain). 
1
H NMR (400 MHz, CDCl3) δ 7.32 (m, 2H, ArH), 7.22 (m, 2H, ArH), 
3.31 (d, J = 14.2 Hz, 1H, CH2Ar), 3.19 (d, J = 14.2 Hz, 1H, CH2Ar), 2.68 (dt, J = 17.9, 9.7 Hz, 
1H, O2CCH2CH2), 2.33 (ddd, J = 17.9, 9.4, 3.2 Hz, 1H, O2CCH2CH2), 2.15 (m, 1H, 
O2CCH2CH2), 2.03 (m, 1H, O2CCH2CH2). 
13
C NMR (101 MHz, CDCl3) δ 174.6, 134.0, 131.8, 
131.6, 129.0, 99.1, 43.1, 31.3, 28.2. IR 2990 (w), 2936 (w), 2116 (s), 1796 (s), 1493 (m), 1249 
(m), 1165 (m), 1017 (m), 911 (s).  HRMS (ESI) calcd for C11H1lClNO2
+
 [M-N2+H]
+
 224.0484; 
found 224.0480. 
 
5-Azido-5-(4-methylbenzyl)dihydrofuran-2(3H)-one (4e) 
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Starting from 4-(p-tolyl)pent-4-enoic acid 1b (73 mg, 0.38 mmol, 1.0 equiv), using 4.0 mg of 
Pd(hfacac)2 (2 mol%, 7.7 mol) and 0.17 g of ADBX 3b (1.5 equiv., 0.57 mmol) the crude 
product (64% NMR yield) was purified by column chromatography (Pentane/EtOAc = 9:1 to 8/2) 
to afford 4e as pale yellow oil (42 mg, 0.18 mmol, 48 % yield). Rf: 0.38 (Pentane/ EtOAc = 8:2) 
(KMnO4 Stain). 
1
H NMR (400 MHz, CDCl3) δ 7.21 – 7.09 (m, 4H, ArH), 3.30 (d, J = 14.1 Hz, 
1H, CH2Ar), 3.18 (d, J = 14.2 Hz, 1H, CH2Ar), 2.70 – 2.55 (m, 1H, O2CCH2CH2), 2.34 (s, 3H, 
Me), 2.30 – 2.14 (m, 2H, O2CCH2CH2 + O2CCH2CH2), 2.09 – 1.93 (m, 1H, O2CCH2CH2). 13C 
NMR (101 MHz, CDCl3) δ 174.8, 137.5, 130.3, 130.0, 129.4, 99.6, 43.2, 31.1, 28.3, 21.0. IR 
3564 (w), 3330 (w), 3008 (w), 2925 (w), 2860 (w), 2454 (w), 2112 (s), 1785 (s), 1615 (w), 1516 
(w), 1454 (w), 1419 (w), 1383 (w), 1330 (w), 1247 (s), 1159 (s), 1116 (w), 1067 (w), 1029 (m), 
911 (s), 875 (w), 847 (w), 822 (w). HRMS (ESI) calcd for C12H13N3NaO2
+
 [M+Na]
+
 254.0900; 
found 254.0903. 
 
5-Azido-5-(2,5-dimethylbenzyl)dihydrofuran-2(3H)-one (4f) 
 
Starting from 1l (61 mg, 0.30 mmol, 1.0 equiv.), the crude product (55% NMR yield) was 
purified by column chromatography (Pentane/EtOAc = 9:1 to 8/2) to afford 4f as a mixture 
(40/60 by 
1
H-NMR) with 2-(2-iodophenyl)propan-2-ol (74 mg total, 30 mg of azidolactone 
calculated, 0.12 mmol, 40 % yield). Rf: 0.30 (Pentane/ EtOAc = 8:2) (KMnO4 Stain). Two 
rotamers are observed in NMR analysis, however they are not fully resolved. Only the major 
rotamer is described. 
1
H NMR (400 MHz, CDCl3) δ 7.16 – 6.96 (m, 3H, ArH), 3.39 (d, J = 14.5 
Hz, 1H, CH2Ar), 3.19 (d, J = 14.4 Hz, 1H, CH2Ar), 2.66 (dt, J = 17.5, 9.5 Hz, 1H, O2CCH2CH2), 
2.34 (s, 3H, Me), 2.30 (s, 3H, Me), 2.28 – 2.21 (m, 1H, O2CCH2CH2), 2.21 – 2.13 (m, 1H, 
O2CCH2CH2), 2.07 (ddd, J = 12.5, 9.2, 3.0 Hz, 1H, O2CCH2CH2). 
13
C NMR (101 MHz, CDCl3) 
δ 174.7, 135.6, 134.2, 132.0, 131.3, 130.7, 128.6, 99.8, 40.0, 31.2, 28.2, 20.9, 19.6. HRMS (ESI) 
calcd for C13H16N3O2
+
 [M-N2+H]
+
 218.1181; found 218.1180. 
 
2-(2-Iodophenyl)propan-2-ol 
 
1
H NMR (400 MHz, CDCl3) δ 7.96 (dd, J = 7.8, 1.4 Hz, 1H, ArH), 7.63 (dd, J = 8.0, 1.7 Hz, 1H, 
ArH), 7.33 (ddd, J = 7.9, 7.3, 1.4 Hz, 1H, ArH), 6.96 – 6.80 (m, 1H, ArH), 2.41 (s, 1H, OH), 1.76 
(s, 6H, Me). 
13
C NMR (101 MHz, CDCl3) 148.5, 142.7, 128.6, 128.1, 126.7, 93.1, 73.6, 29.8. 
NMR data correspond to the reported values. 
[29]
  
 
5-Azido-5-(thiophen-3-ylmethyl)dihydrofuran-2(3H)-one (4g) 
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Starting from 1k (55 mg, 0.30 mmol, 1.0 equiv.), the crude product (60% NMR yield) was 
purified by column chromatography (Pentane/Ethyl Acetate = 9:1 then 8:2) to afford 4g as 
colorless oil (34 mg, 0.16 mmol, 52 %). 
1
H NMR (400 MHz, CDCl3) δ 7.32 (dd, J = 5.0, 3.0 Hz, 
1H, ArH), 7.19 (dd, J = 2.9, 1.2 Hz, 1H, ArH), 7.05 (dd, J = 4.9, 1.3 Hz, 1H, ArH), 3.36 (d, J = 
14.6 Hz, 1H, ArCH2), 3.29 (d, J = 14.6 Hz, 1H, ArCH2), 2.67 (dt, J = 17.7, 9.5 Hz, 1H, 
O2CCH2CH2), 2.31 (ddd, J = 17.7, 9.5, 3.4 Hz, 1H, O2CCH2CH2), 2.19 (dt, J = 13.3, 9.4 Hz, 1H, 
O2CCH2CH2), 2.05 (ddd, J = 13.2, 9.6, 3.4 Hz, 1H, O2CCH2CH2). 
13
C NMR (100 MHz, CDCl3) 
δ 174.7, 133.2, 129.1, 126.3, 124.7, 99.1, 38.4, 31.4, 28.3. IR 3106 (w), 2932 (w), 2863 (w), 
2453 (w), 2254 (w), 2116 (s), 1793 (s), 1606 (w), 1451 (w), 1422 (w), 1242 (m), 1162 (s), 1075 
(w), 1031 (m), 949 (w), 911 (s), 848 (w). HRMS (APCI) calcd for C9H10NO2S
+
 [M-N2+H]
+
 
196.0427; found 196.0426. 
 
5-Azido-5-benzyl-3,3-dimethyldihydrofuran-2(3H)-one (4h) 
 
Starting from 2,2-dimethyl-4-phenylpent-4-enoic acid 1j (61 mg, 0.30 mmol, 1.0 equiv.), the 
crude product (81% NMR yield) was purified by column chromatography (Pentane/EtOAc = 9:1 
to 8/2) to afford 4h as pale orange oil (57 mg, 0.23 mmol, 77 % yield). Rf: 0.50 (Pentane/ EtOAc 
= 8:2) (KMnO4 Stain). 
1
H NMR (400 MHz, CDCl3) δ 7.37 – 7.22 (m, 5H), 3.33 (d, J = 14.1 Hz, 
1H, CH2Ar), 3.20 (d, J = 14.1 Hz, 1H, CH2Ar), 2.10 (d, J = 13.7 Hz, 1H, CCH2CMe2), 1.92 (d, J 
= 13.8 Hz, 1H, CCH2CMe2), 1.35 (s, 3H, CH3), 0.99 (s, 3H, CH3). 
13
C NMR (101 MHz, CDCl3) 
δ 180.6, 133.4, 130.7, 128.8, 127.9, 96.5, 44.9, 44.4, 40.4, 26.5, 26.0. IR 3065 (w), 2976 (w), 
2934 (w), 2114 (s), 1785 (s), 1456 (w), 1258 (m), 1229 (s), 1129 (m), 1037 (m), 908 (s). HRMS 
(ESI) calcd for C13H15N3NaO2
+
 [M+Na]
+
 268.1056; found 268.1056. 
 
3-Azido-3-benzylisobenzofuran-1(3H)-one (4i) 
 
Starting from 2-(1-phenylvinyl)benzoic acid 1h (67 mg, 0.30 mmol, 1.0 equiv.), the crude 
product (75% NMR yield) was purified by column chromatography (Pentane/EtOAc = 9:1 to 8/2) 
to afford 4i as a mixture (60/40 by 
1
H-NMR) with 2-(2-iodophenyl)propan-2-ol (98 mg total, 59 
mg of azidolactone calculated, 0.22 mmol, 74 % yield). Rf: 0.30 (Pentane/ EtOAc = 8:2) 
(KMnO4 Stain/UV). 
1
H NMR (400 MHz, CDCl3) δ 7.77 (dd, J = 7.6, 0.9 Hz, 1H, ArH), 7.71 (td, 
J = 7.6, 1.1 Hz, 1H, ArH), 7.56 (td, J = 7.5, 1.0 Hz, 1H, ArH), 7.38 (d, J = 7.7 Hz, 1H, ArH), 
7.19 (dd, J = 5.0, 2.0 Hz, 3H, ArH), 7.09 (dd, J = 6.7, 3.0 Hz, 2H, ArH), 3.38 (s, 2H, CH2Ar). 
13
C NMR (101 MHz, CDCl3) δ 167.1, 148.5, 134.6, 132.3, 130.9, 130.7, 128.2, 127.5, 126.2, 
125.7, 122.6, 98.8, 44.2. HRMS (ESI) calcd for C15H12N3O2
+
 [M-N2+H]
+
 238.0868; found 
238.0873. 
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3-Azido-3-(4-chlorobenzyl)isobenzofuran-1(3H)-one (4j) 
 
Starting from 2-(1-(4-chlorophenyl)vinyl)benzoic acid 1w (78 mg, 0.30 mmol, 1.0 equiv.), the 
crude product (78% NMR yield) was purified by column chromatography (Pentane/EtOAc = 9:1 
to 8/2) to afford 4j as pale yellow oil (67 mg, 0.22 mmol, 74 % yield). Rf: 0.25 (Pentane/ EtOAc 
= 8:2) (KMnO4 Stain/UV). 
1
H NMR (400 MHz, CDCl3) δ 7.80 (d, J = 7.7 Hz, 1H, ArH), 7.73 
(td, J = 7.5, 1.1 Hz, 1H, ArH), 7.59 (td, J = 7.6, 0.9 Hz, 1H, ArH), 7.41 (dd, J = 7.7, 0.9 Hz, 1H, 
ArH), 7.17 (d, J = 8.4 Hz, 2H, ArH), 7.03 (d, J = 8.4 Hz, 2H, ArH), 3.41 – 3.26 (m, 2H, ArCH2). 
13
C NMR (101 MHz, CDCl3) δ 166.9, 145.9, 134.9, 133.7, 132.0, 131.2, 130.9, 128.5, 126.3, 
126.0, 122.5, 98.5, 43.7. IR 3553 (w), 3064 (w), 2840 (w), 2433 (w), 2116 (s), 1784 (s), 1602 
(w), 1493 (w), 1469 (w), 1435 (w), 1410 (w), 1349 (w), 1275 (m), 1239 (m), 1209 (w), 1160 (w), 
1087 (m), 1014 (w), 956 (m), 906 (w), 844 (w), 817 (w). HRMS (ESI) calcd for C15H10ClNO2
+
 
[M-N2+H]
+
 272.0478; found 272.0481. 
 
 
3-Azido-3-(4-fluorobenzyl)isobenzofuran-1(3H)-one (4k) 
 
Starting from 2-(1-(4-Fluorophenyl)vinyl)benzoic acid 1i, the crude product (75% NMR yield) 
was purified by column chromatography (Pentane/EtOAc = 9:1 to 8/2) to afford 4k as a mixture 
(40/60 by 
1
H-NMR) with 2-(2-iodophenyl)propan-2-ol (122 mg total, 51 mg of azidolactone 
calculated, 0.18 mmol, 60 % yield). Rf: 0.30 (Pentane/ EtOAc = 8:2) (KMnO4 Stain/UV). 
Always used directly as crude material for product modification. 
1
H NMR (400 MHz, CDCl3) δ 
7.79 (d, J = 7.6 Hz, 1H, ArH), 7.73 (td, J = 7.5, 1.1 Hz, 1H, ArH), 7.57 (t, J = 7.6 Hz, 1H, ArH), 
7.40 (d, J = 7.7 Hz, 1H, ArH), 7.11 – 7.01 (m, 2H, ArH), 6.87 (d, J = 8.5 Hz, 2H, ArH), 3.38 (d, J 
= 14.2 Hz, 1H, CH2Ar), 3.32 (d, J = 14.2 Hz, 1H, CH2Ar). 
13
C NMR (101 MHz, CDCl3) δ 167.0, 
162.3 (d, J = 246.3 Hz), 145.9, 134.8, 132.3 (d, J = 8.1 Hz), 131.1, 128.1 (overlapping with 2-(2-
iodophenyl)propan-2-ol), 126.3, 125.9, 122.5, 115.2 (d, J = 21.3 Hz), 98.7, 43.5. 
19
F NMR (376 
MHz, CDCl3) δ 114.51 (m, 1F). HRMS (ESI) calcd for C15H11FNO2
+
 [M-N2+H]
+
 256.0768; 
found 256.0779.  
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7. Pd-Catalyzed Synthesis of (1,2)-Azidolactones 
General procedure 
 
Dry acetonitrile (1.5 mL) was added in a flame dried 4 mL test tube containing a teflon coated 
stirring bar, the enoic acid 1 (0.30 mmol, 1.0 equiv), ADBX reagent 3b (136 mg, 0.450 mmol, 
1.5 equiv) and Pd(hfacac)2 (3.1 mg, 6.0 mol, 0.02 equiv.). The resulting solution was stirred 
under N2 at room temperature for 2 h unless otherwise noted. After completion of the reaction, 
the crude mixture was obtained after concentration under reduced pressure. Final purification was 
performed by column chromatography (Pentane/EtOAc : 100 to 90/10 to 80/20) over silica gel 
affording the corresponding azidolactone product 2. 
 
5-(Azidomethyl)-5-(3-phenylpropyl)dihydrofuran-2(3H)-one (2s) 
  
Starting from 4-Methylene-7-phenylheptanoic acid 1s (55 mg, 0.25 mmol, 1.0 equiv.), 
Pd(hfacac)2 (2.6 mg, 5.0 mol, 0.02 equiv), ADBX 3b (115 mg, 0.378 mmol, 1.5 equiv), the 
crude product (40 % NMR yield, using 5 L of CH2Br2 as internal standard) was purified by 
column chromatography (Pentane/Ethyl Acetate = 9:1 then 8:2) to afford 2s as colorless oil (13 
mg, 0.050 mmol, 20 % yield). 
1
H NMR (400 MHz, CDCl3) δ 7.29 (dd, J = 8.1, 6.6 Hz, 2H, 
ArH), 7.24 – 7.18 (m, 1H, ArH), 7.18 – 7.13 (m, 2H, ArH), 3.51 (d, J = 12.8 Hz, 1H, CH2N3), 
3.35 (d, J = 12.8 Hz, 1H, CH2N3), 2.76 – 2.66 (m, 1H, O2CCH2CH2), 2.66 – 2.61 (m, 2H, 
ArCH2CH2CH2), 2.55 (ddd, J = 18.2, 10.6, 5.9 Hz, 1H, O2CCH2CH2), 2.16 (ddd, J = 13.3, 10.7, 
5.9 Hz, 1H, O2CCH2CH2), 1.99 (ddd, J = 13.3, 10.6, 7.4 Hz, 1H, O2CCH2CH2), 1.78 – 1.64 (m, 
4H, ArCH2CH2CH2). 
13
C NMR (100 MHz, CDCl3) δ 176.1, 141.2, 128.5, 128.3, 126.1, 86.6, 
57.7, 37.2, 35.7, 28.9, 28.6, 25.0. IR 3061 (w), 3028 (w), 2945 (w), 2869 (w), 2108 (s), 1777 (s), 
1604 (w), 1495 (w), 1455 (w), 1281 (m), 1241 (m), 1198 (m), 1168 (m), 1083 (w), 1027 (w), 946 
(m), 917 (w), 847 (w). HRMS (ESI) calcd for C14H17N3NaO2
+
 [M+Na]
+
 282.1213; found 
282.1215. 
 
3-(Azidomethyl)-3-methylisobenzofuran-1(3H)-one (2g) 
 
Starting from 2-(prop-1-en-2-yl)benzoic acid 1g (32 mg, 0.20 mmol, 1.0 equiv.), ADBX reagent 
3b (92 mg, 0.30 mmol, 1.5 equiv) and Pd(hfacac)2 (2.1 mg, 4.0 mol, 0.02 equiv.), the crude 
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product was purified by column chromatography (Pentane/EtOAc = 9:1 to 8/2) to afford 2g as 
white solid (20 mg, 0.104 mmol, 50 % yield). Rf: 0.55 (Pentane/ EtOAc = 8:2) (Seebach Stain). 
1
H NMR (400 MHz, CDCl3) δ 7.91 (d, J = 7.6 Hz, 1H, ArH), 7.70 (t, J = 7.5 Hz, 1H, ArH), 7.57 
(t, J = 7.5 Hz, 1H, ArH), 7.45 (d, J = 7.7 Hz, 1H, ArH), 3.65 (m, 2H, CH2N3), 1.69 (s, 3H, CH3). 
13
C NMR (101 MHz, CDCl3) δ 169.1, 150.8, 134.5, 129.8, 126.1, 126.1, 121.3, 85.8, 58.1, 23.2. 
IR 3055 (w), 2985 (w), 2933 (w), 2105 (s), 1761 (s), 1468 (w), 1288 (m), 1035 (s). HRMS (ESI) 
calcd for C10H9N3NaO2
+
 [M+Na]
+
 226.0587; found 226.0588. Melting point : 77 °C. 
 
3-(Azidomethyl)isochroman-1-one (2t) 
 
Starting from 2-allylbenzoic acid 1t (32 mg, 0.20 mmol, 1.0 equiv.), ADBX reagent 3b (92 mg, 
0.30 mmol, 1.5 equiv) and Pd(hfacac)2 (2.1 mg, 4.0 mol, 0.02 equiv.), the crude product was 
purified by column chromatography (Pentane/EtOAc = 9:1 to 8/2) to afford 2t as pale yellow oil 
(29 mg, 0.14 mmol, 71 % yield). 
1
H NMR (400 MHz, CDCl3) δ 8.12 – 8.00 (m, 1H, ArH), 7.51 
(td, J = 7.5, 1.5 Hz, 1H, ArH), 7.35 (t, J = 7.6 Hz, 1H, ArH), 7.22 (d, J = 7.5 Hz, 1H, ArH), 4.69 
– 4.53 (m, 1H, CH), 3.67 – 3.49 (m, 2H, CH2N3), 3.12 (dd, J = 16.3, 11.8 Hz, 1H, ArCH2CH), 
2.87 (dd, J = 16.3, 3.2 Hz, 1H, ArCH2CH). 
13
C NMR (101 MHz, CDCl3) δ 164.6, 138.3, 134.3, 
130.6, 128.1, 127.8, 124.7, 76.8, 53.8, 30.5. IR 3614 (s), 3075 (w), 3074 (w), 3038 (w), 3038 
(w), 2930 (w), 2929 (w), 2928 (w), 2920 (w), 2104 (m), 1726 (m), 1609 (w), 1462 (w), 1362 (w), 
1271 (m), 1228 (w), 1126 (m), 1086 (m), 1033 (w), 950 (w), 935 (w), 905 (w). HRMS (ESI) 
calcd for C10H9N3NaO2
+
 [M+Na]
+
 226.0587; found 226.0591. 
 
3-(Azidomethyl)-3-methylisochroman-1-one (2u) 
 
Starting from 2-(2-methylallyl)benzoic acid 1u (53 mg, 0.30 mmol, 1.0 equiv.), Pd(hfacac)2 (3 
mg, 6 μmol, 2 mol %), and ADBX 3b (137 mg, 0.450 mmol, 1.5 equiv.)  and 20 hours of 
reaction, the crude product was purified by column chromatography (Pentane/EtOAc = 9:1 to 
8/2) to afford 2u as pale yellow oil (44 mg, 0.20 mmol, 68% yield) as a dark yellow viscous oil. 
Rf: 0.25 (Pentane/EtOAc 7/1). 
1
H NMR (400 MHz, CDCl3) δ 8.09 (d, J = 7.8 Hz, 1H, ArH), 7.56 
(t, J = 7.5 Hz, 1H, ArH), 7.40 (t, J = 7.7 Hz, 1H, ArH), 7.25 (d, J = 7.7 Hz, 1H, ArH), 3.54 (d, J = 
12.7 Hz, 1H, ArCH2), 3.40 (d, J = 12.7 Hz, 1H, ArCH2), 3.31 (d, J = 16.4 Hz, 1H, N3CH2), 2.88 
(d, J = 16.4 Hz, 1H, N3CH2), 1.43 (d, J = 1.6 Hz, 3H, CH3).
13
C NMR (101 MHz, CDCl3) δ 
163.9, 137.0, 134.2, 130.1, 128.1, 127.7, 124.2, 81.6, 58.1, 34.8, 23.4. IR 3432 (w), 3070 (w), 
2983 (w), 2937 (w), 2108 (s), 1721 (s), 1607 (w), 1459 (w), 1389 (w), 1289 (s), 1236 (m), 1168 
(w), 1114 (m), 1080 (m), 1036 (w), 950 (w), 841 (w). HRMS (ESI) calcd for C11H11N3NaO2
+
 
[M+Na]
+
 240.0743; found 240.0748 
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3-(Azidomethyl)-3-((benzyloxy)methyl)isochroman-1-one (2v) 
 
Starting from 2-(2-((benzyloxy)methyl)allyl)benzoic acid 1v (85 mg, 0.30 mmol, 1.0 equiv.), 
Pd(hfacac)2 (15.0 mg, 0.029 mmol, 10 mol %), and ADBX 3b (137 mg, 0.450 mmol, 1.5 equiv.)  
and 20 h of reaction, the crude product was purified by column chromatography (Pentane/EtOAc 
= 9:1 to 8/2) to afford 2v as pale yellow oil (50.8 mg, 0.141 mmol, 90% purity, 45% yield). A ≥ 
95% pure sample was obtained through preparative TLC (20 x 20 sqcm plate; 
pentane/DCM/EtOAc 18/1/1). Rf = 0.56 (pentane/EtOAc 5/1) (KMnO4 Stain). 
1
H NMR (400 
MHz, CDCl3) δ 8.07 (dd, J = 7.8, 1.3 Hz, 1H, ArH), 7.56 (td, J = 7.5, 1.5 Hz, 1H, ArH), 7.39 (td, 
J = 7.7, 1.2 Hz, 1H, ArH), 7.35 – 7.27 (m, 3H, ArH + PhH), 7.25 – 7.21 (m, 3H, PhH), 4.56 (d, J 
= 12.0 Hz, 1H, PhCH2O), 4.49 (d, J = 12.0 Hz, 1H, PhCH2O), 3.63 (d, J = 9.7 Hz, 1H, CCH2O), 
3.59 (d, J = 9.9 Hz, 2H, aliphatic CH2), 3.52 (d, J = 9.8 Hz, 1H, CCH2O), 3.20 (d, J = 16.7 Hz, 
1H, aliphatic CH2), 3.14 (d, J = 16.7 Hz, 1H, aliphatic CH2). 
13
C NMR (101 MHz, CDCl3) δ 
163.3, 137.2, 136.6, 134.2, 130.2, 128.4, 128.1, 127.9, 127.7, 127.6, 124.2, 82.6, 73.6, 70.6, 54.8, 
30.6. IR 3065 (w), 3035 (w), 2921 (w), 2868 (w), 2105 (s), 1727 (s), 1607 (w), 1488 (w), 1455 
(w), 1360 (w), 1283 (s), 1107 (s), 1024 (w), 959 (w), 920 (w), 919 (w). HRMS (ESI) calcd for 
C18H17N3NaO3
+
 [M+Na]
+
 346.1162; found 346.1161. 
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8. Derivatizations  
4-Oxo-5-phenylpentanoic acid (5) 
 
Dry acetonitrile (1.5 mL) was added in a flame dried 4 mL test tube containing a teflon coated 
stirring bar, the enoic acid 1a (53 mg, 0.30 mmol, 1.0 equiv), ADBX reagent 3b (136 mg, 0.450 
mmol, 1.5 equiv) and Pd(hfacac)2 (3.1 mg, 6.0 mol, 0.02 equiv.). The resulting solution was 
stirred under N2 at room temperature for 3 h. After completion of the reaction, the crude mixture 
was obtained after concentration under reduced pressure. Then addition of 18 L of CH2Br2 as 
internal standard showed 80-85% NMR yield. Evaporation of CDCl3 and CH2Br2 under reduced 
pressure gave back the crude material, which was directly used without any purification. Pd/C 
(32 mg, 15 mol, 5 mol%, loading 5% in Pd) and EtOAc (1.5 mL, 0.2 M) were introduced. After 
bubbling H2 (with balloon) for 5 min, the solution was stirred for 48h at rt under 1 atmosphere of 
H2. Then the reaction mixture was filtered using HPLC filter to remove solid Pd/C, before being 
concentrated under reduced pressure. The crude material was purified by column 
chromatography, affording 6 (43 mg, 0.22 mmol) in 75% yield over two steps. 
1
H NMR (400 
MHz, CDCl3) δ 7.36 – 7.31 (m, 2H, ArH), 7.30 – 7.25 (m, 1H, ArH), 7.21 (m, 2H, ArH), 3.74 (s, 
2H, ArCH2), 2.75 (t, J = 6.5 Hz, 2H, CH2CH2CO2H), 2.61 (t, J = 6.5 Hz, 2H, CH2CH2CO2H). 
13
C 
NMR (101 MHz, CDCl3) δ 206.4, 177.9, 134.0, 129.6, 128.9, 127.3, 50.1, 36.3, 27.9. NMR data 
correspond to the reported values.
[30]
 
 
3-(4-Fluorobenzyl)-3-(4-phenyl-1H-1,2,3-triazol-1-yl)isobenzofuran-1(3H)-one (6) 
 
Dry acetonitrile (1.0 mL) was added in a flame dried 4 mL test tube containing a teflon coated 
stirring bar, the enoic acid 1i (48 mg, 0.20 mmol, 1.0 equiv), ADBX reagent 3b (91 mg, 0.30 
mmol, 1.5 equiv) and Pd(hfacac)2 (2.1 mg, 4.0 mol, 0.02 equiv.). The resulting solution was 
stirred under N2 at room temperature for 2 h. After completion of the reaction, the crude mixture 
was obtained after concentration under reduced pressure. Then addition of 6 L of CH2Br2 as 
internal standard showed 75% NMR yield. Evaporation of CDCl3 and CH2Br2 under reduced 
pressure gave back the crude material which was directly used without any purification. 
Quantities of triethylamine (42 L, 0.30 mmol, 2.0 equiv) and copper iodide (2.9 mg, mol, 0.10 
equiv), ethynylbenzene (33 l, 0.30 mmol, 2.0 equiv) and THF (0.75 mL, 0.20 M) were 
calculated considering 75% yield, meaning 0.15 mmol of azidolactone. All the reagents were 
introduced under nitrogen and the reaction mixture was stirred overnight (16h) at room 
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temperature. After completion of the reaction, the resulting mixture was concentrated under 
reduced pressure and purified by preparative TLC using 60/40 pentane/ethylacetate as eluent 
system, affording 8 in 65% isolated yield after two steps. (50 mg, 0.13 mmol). 
1
H NMR (400 
MHz, CDCl3) δ 7.98 (dd, J = 7.7, 1.0 Hz, 1H, ArH), 7.81 (ddd, J = 7.5, 4.7, 1.1 Hz, 2H, ArH), 
7.79 – 7.72 (m, 3H, ArH + NCH), 7.62 (td, J = 7.5, 0.9 Hz, 1H, ArH), 7.44 – 7.36 (m, 2H, ArH), 
7.36 – 7.28 (m, 1H, ArH), 7.01 (dd, J = 8.6, 5.4 Hz, 2H, ArH), 6.84 (t, J = 8.6 Hz, 2H, ArH), 4.09 
(d, J = 14.4 Hz, 1H, ArCH2), 3.88 (d, J = 14.3 Hz, 1H, ArCH2). 
13
C NMR (100 MHz, CDCl3) 
166.5, 162.3 (d, J = 247.1 Hz), 147.56, 146.5, 135.3, 132.2 (d, J = 8.3 Hz), 131.4, 129.8, 128.8, 
128.5, 127.3 (d, J = 3.4 Hz), 126.0, 125.7, 125.0, 124.2, 117.9, 115.3 (d, J = 21.5 Hz), 95.8, 44.3. 
19
F NMR (376 MHz, CDCl3) δ -114.07 (m, 1F). IR 3145 (w), 3065 (w), 2885 (w), 2253 (w), 
2148 (w), 1894 (w), 1789 (s), 1607 (w), 1512 (m), 1475 (w), 1464 (w), 1415 (m), 1353 (w), 1279 
(m), 1228 (m), 1160 (w), 1075 (m), 1029 (w), 971 (s), 915 (m), 840 (m). HRMS (ESI) calcd for 
C23H16FN3NaO2
+
 [M+Na]
+
 408.1119; found 408.1111.  Melting point: 141.7-148.5 °C 
(decomp.).  
 
 
Methyl 4-oxo-5-phenylpentanoate (7) 
 
Dry acetonitrile (1.5 mL) was added in a flame dried 4 mL test tube containing a teflon coated 
stirring bar, the enoic acid 1a (53 mg, 0.30 mmol, 1.0 equiv), ADBX reagent 3b (136 mg, 0.450 
mmol, 1.5 equiv) and Pd(hfacac)2 (3.1 mg, 6.0 mol, 0.02 equiv.). The resulting solution was 
stirred under N2 at room temperature for 3 h. After completion of the reaction, the crude mixture 
was obtained after concentration under reduced pressure. Then addition of 18 L of CH2Br2 as 
internal standard showed 80-85% NMR yield. Evaporation of CDCl3 and CH2Br2 under reduced 
pressure gave back the crude material, which was directly used without any purification. Pd/C 
(16 mg, 7.5 mol, 2.5 mol%, loading 5% in Pd) and Methanol (1.5 mL, 0.2 M) were introduced. 
After bubbling H2 (with balloon) for 5 min, the solution was stirred for 24h at rt under 1 
atmosphere of H2. Full conversion was confirmed by TLC (90/10 pentane/ethylacetate), then the 
reaction mixture was filtered using HPLC filter to remove solid Pd/C. The vial was rinsed 3 times 
using EtOAc before being concentrated under reduced pressure and purified by preparative 
column chromatography over silicagel, using 90/10 pentane/ethylacetate as eluent system, 
affording 8 as a pale yellow oil in 70% isolated yield after two steps. (43 mg, 0.21 mmol).
1
H 
NMR (400 MHz, CDCl3) δ 7.37 - 7.30 (m, 2H, ArH), 7.30 - 7.16 (m, 3H, ArH), 3.74 (s, 2H, 
CH2Ar), 3.65 (s, 3H, Me), 2.76 (t, J = 6.6 Hz, 2H, CH2CH2COOMe), 2.56 (t, J = 6.6 Hz, 2H, 
CH2CH2COOMe).
13
C NMR (101 MHz, CDCl3) δ 206.4, 173.1, 134.0, 129.4, 128.7, 127.0, 51.7, 
50.0, 36.4, 27.7. NMR data correspond to the reported values.
[21]
 
 
4-((tert-Butoxycarbonyl)amino)-5-(4-chlorophenyl)pentanoic acid (8) 
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In a flame dried 4 mL test-tube were introduced azido lactone 4d (25 mg, 0.10 mmol) and THF 
(1.0 mL, 0.10 M) under nitrogen. To this solution was added black platinum (2.0 mg, 10 mmol, 
0.10 equiv) and Boc2O (44 mg, 0.20 mmol, 2.0 equiv.), before being placed under H2 pressure 
(1atm, balloon). The resulting solution was stirred for 18h at room temperature. Filtration using 
HPLC filter and evaporation of the solvent under reduced pressure gave the crude mixture as a 
solid-oil mixture. Final precipitation was obtained by adding chloroform. After two washing 
sequence with chloroform, the expected product 9 was isolated as colorless solid (16 mg, 0.048 
mmol, 48 % yield). NB: Mixture of rotamers not fully resolved (M stands for major rotamer, m 
stands for minor rotamer). (NMR ratio: 86:14). 
1
H NMR (400 MHz, DMSO-d6) δ 12.01 (s, 1H, 
COOH (M+m)), 7.38 (d, J = 8.4 Hz, 0.13H, ArH (m)), 7.32 (d, J = 8.3 Hz, 1.87H, ArH (M)), 
7.23 – 7.15 (d, J = 8.3 Hz, 2H, ArH (M+m)), 6.72 (d, J = 8.9 Hz, 0.86H, NH (M)), 6.31 (d, J = 
9.2 Hz, 0.14H, NH (m)), 3.66 – 3.49 (m, 1H, NCH (M+m)), 2.65 (m, 2H, ArCH2 (M+m)), 2.30 – 
2.13 (m, 2H, CH2CH2COOH (M+m)), 1.67 (m, 1H, CH2CH2COOH (M+m)), 1.52 (m, 1H, 
CH2CH2COOH (M+m)), 1.32 (s, 7.5H, Boc (M)), 1.23 (s, 1.5H, Boc (m)). 
13
C NMR (100 MHz, 
DMSO-d6) (only major rotamer) δ 174.2, 155.2, 138.1, 131.0, 130.5, 127.9, 77.3, 51.0, 40.1, 
30.4, 29.5, 28.2. IR 3359 (w), 2975 (m), 2934 (m), 2605 (w), 2260 (w), 2118 (w), 1902 (w), 1695 
(s), 1521 (m), 1448 (w), 1402 (m), 1363 (m), 1257 (m), 1170 (s), 1093 (w), 1024 (s), 900 (w), 
818 (w). HRMS (ESI) calcd for C16H21ClNO4
-
 [M-H]
-
 326.1165; found 326.1156; Melting 
point: 146.9 – 147.9 °C. 
 
3-Amino-3-(4-fluorobenzyl)isobenzofuran-1(3H)-one (9) 
 
In a flame dried 4 mL test-tube were introduced unseparated iodoalcohol and azido lactone 4k 
(51 mg, 0.18 mmol, based on NMR yield) and THF (1.8 mL, 0.10 M) under nitrogen. To this 
solution was added black platinum (3.5 mg, 18 mol, 0.10 equiv) and Boc2O (79 mg, 0.36 mmol, 
2.0 equiv), before being placed under H2 pressure (1atm, balloon). The resulting solution was 
stirred for 15h at room temperature. Filtration using HPLC filter and evaporation of the solvent 
under reduced pressure gave the crude mixture. Purification using preparative TLC using 55/45 
pentane/ethyl acetate as eluant afforded primary amine product 10 as colorless solid (37 mg, 0.14 
mmol, 80 % yield). No N-Boc protected amine was observed. The reaction was scaled up to 420 
mg of azidolactone 4k (1.48 mmol) dissolved in 14 mL of THF and using only black platinum 
catalyst (29 mg, 0.15 mmol, 0.10 equiv). In this case, 80% conversion and 53% yield of 9 was 
obtained (203 mg, 0.789 mmol). 
1
H NMR (400 MHz, CDCl3) δ 7.76 (d, J = 7.1 Hz, 1H, ArH), 
7.67 (td, J = 7.3, 1.1 Hz, 1H, ArH), 7.52 (t, J = 7.3 Hz, 2H, ArH), 7.20 – 7.12 (m, 2H, ArFH), 
6.97 – 6.87 (m (app tt), 2H, ArFH), 3.26 (s, 2H, ArFCH2), 2.52 (brs, 2H, NH2). 
13
C NMR (100 
MHz, CDCl3) δ 168.5, 162.2 (d, J = 246.0 Hz), 149.3, 134.0, 132.3 (d, J = 8.0 Hz), 130.2, 129.6 
(d, J = 3.3 Hz), 127.7, 125.3, 122.8, 115.1 (d, J = 21.3 Hz), 98.7, 45.9. 
19
F NMR (376 MHz, 
CDCl3) δ -115.15 (m, 1F). IR 3403 (w), 3337 (w), 3235 (w), 3059 (w), 2927 (w), 2857 (w), 2254 
(w), 1751 (s), 1611 (w), 1511 (m), 1475 (w), 1429 (w), 1383 (w), 1284 (m), 1229 (m), 1156 (w), 
1120 (m), 1088 (w), 1010 (w), 942 (w), 867 (m), 838 (w). HRMS (ESI) calcd for 
C15H12FNNaO2
+
 [M+Na]
+
 280.0744; found 280.0741. Melting point: 132.7-135.7 °C (decomp.). 
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9. Spectra of compounds 
 Spectra of new compounds of starting materials a.
 
1
H NMR (400 MHz, CDCl3) of compound 4-(2,5-dimethylphenyl)pent-4-enoic acid (1l) 
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13
C NMR (101 MHz, CDCl3) of compound 4-(2,5-dimethylphenyl)pent-4-enoic acid (1l) 
 
 
IR of compound 4-(2,5-dimethylphenyl)pent-4-enoic acid (1l) 
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1
H NMR (400 MHz, CDCl3) of compound 2-(1-methylene-2,3-dihydro-1H-inden-2-yl)acetic 
acid (1m) 
 
13
C NMR (101 MHz, CDCl3) of compound 2-(1-methylene-2,3-dihydro-1H-inden-2-yl)acetic 
acid (1m) 
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IR of compound 2-(1-methylene-2,3-dihydro-1H-inden-2-yl)acetic acid (1m) 
 
 
 
1
H-NMR (400 MHz, (CD3)2CO) of compound 4-methylene-7-phenylheptanoic acid (1s) 
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13
C-NMR (101 MHz, (CD3)2CO) of compound 4-methylene-7-phenylheptanoic acid (1s)
 
 
IR of compound 4-methylene-7-phenylheptanoic acid (1s) 
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1
H-NMR (400 MHz, CDCl3) of compound 2-(2-((Benzyloxy)methyl)allyl)benzoic acid (1v) 
  
13
C-NMR (101 MHz, CDCl3) of compound 2-(2-((Benzyloxy)methyl)allyl)benzoic acid (1v)
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IR of compound 2-(2-((Benzyloxy)methyl)allyl)benzoic acid (1v) 
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 Spectra of compounds from photoredox catalysis b.
1
H NMR (400 MHz, CDCl3) of compound 5-(azidomethyl)-5-phenyldihydrofuran-2(3H)-one 
(2a) 
 
13
C NMR (101 MHz, CDCl3) of compound 5-(azidomethyl)-5-phenyldihydrofuran-2(3H)-
one (2a) 
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1
H NMR (400 MHz, CDCl3) of compound 5-(azidomethyl)-5-(p-tolyl)dihydrofuran-2(3H)-one 
(2b) 
 
13
C NMR (101 MHz, CDCl3) of compound 5-(azidomethyl)-5-(p-tolyl)dihydrofuran-2(3H)-
one (2b) 
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IR of compound 5-(azidomethyl)-5-(p-tolyl)dihydrofuran-2(3H)-one (2b)  
 
1
H NMR (400 MHz, CDCl3) of compound 5-(azidomethyl)-5-(4-
methoxyphenyl)dihydrofuran-2(3H)-one (2c) 
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13
C NMR (101 MHz, CDCl3) of compound 5-(azidomethyl)-5-(4-
methoxyphenyl)dihydrofuran-2(3H)-one (2c) 
 
 
1
H NMR (400 MHz, CDCl3) of compound 5-(azidomethyl)-5-(4-bromophenyl)dihydrofuran-
2(3H)-one (2d) 
 
S55 
 
13
C NMR (101 MHz, CDCl3) of compound 5-(azidomethyl)-5-(4-bromophenyl)dihydrofuran-
2(3H)-one (2d) 
 
 
1
H NMR (400 MHz, CDCl3) of compound 5-(azidomethyl)-5-(4-fluorophenyl)dihydrofuran-
2(3H)-one (2e) 
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13
C NMR (101 MHz, CDCl3) of compound 5-(azidomethyl)-5-(4-fluorophenyl)dihydrofuran-
2(3H)-one (2e) 
 
 
19
F NMR (376 MHz, CDCl3) of compound 5-(azidomethyl)-5-(4-fluorophenyl)dihydrofuran-
2(3H)-one (2e) 
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IR of compound 5-(azidomethyl)-5-(4-fluorophenyl)dihydrofuran-2(3H)-one (2e) 
 
 
1
H NMR (400 MHz, CDCl3) of compound 5-(azidomethyl)-5-(4-chlorophenyl)dihydrofuran-
2(3H)-one (2f) 
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13
C NMR (101 MHz, CDCl3) of compound 5-(azidomethyl)-5-(4-chlorophenyl)dihydrofuran-
2(3H)-one (2f) 
 
 
1
H NMR (400 MHz, CDCl3) of compound 3-(azidomethyl)-3-methylisobenzofuran-1(3H)-one 
(2g) 
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13
C NMR (101 MHz, CDCl3) of compound 3-(azidomethyl)-3-methylisobenzofuran-1(3H)-
one (2g) 
 
 
IR of compound 3-(azidomethyl)-3-methylisobenzofuran-1(3H)-one (2g) 
 
S60 
 
1
H NMR (400 MHz, CDCl3) of compound 3-(azidomethyl)-3-phenylisobenzofuran-1(3H)-one 
(2h) 
 
13
C-NMR (101 MHz, CDCl3) of compound 3-(azidomethyl)-3-phenylisobenzofuran-1(3H)-
one  (2h) 
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IR of compound 3-(azidomethyl)-3-phenylisobenzofuran-1(3H)-one (2h) 
 
1
H NMR (400 MHz, CDCl3) of compound 3-(azidomethyl)-3-(4-fluorophenyl)isobenzofuran-
1(3H)-one (2i) 
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13
C NMR (101 MHz, CDCl3) of compound 3-(azidomethyl)-3-(4-fluorophenyl)isobenzofuran-
1(3H)-one (2i) 
 
19
F NMR (376 MHz, CDCl3) of compound 3-(azidomethyl)-3-(4-fluorophenyl)isobenzofuran-
1(3H)-one (2i) 
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IR of compound 3-(azidomethyl)-3-(4-fluorophenyl)isobenzofuran-1(3H)-one (2i) 
 
 
 
 
1
H NMR (400 MHz, CDCl3) of compound5-(azidomethyl)-3,3-dimethyl-5-
phenyldihydrofuran-2(3H)-one (2j) 
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13
C NMR (101 MHz, CDCl3) of compound 5-(azidomethyl)-3,3-dimethyl-5-
phenyldihydrofuran-2(3H)-one (2j) 
 
 
 
IR of compound 5-(azidomethyl)-3,3-dimethyl-5-phenyldihydrofuran-2(3H)-one (2j) 
 
 
S65 
 
1
H NMR (400 MHz, CDCl3) of compound 5-(azidomethyl)-5-(thiophen-3-yl)dihydrofuran-
2(3H)-one (2k) 
 
 
13
C NMR (101 MHz, CDCl3) of compound 5-(azidomethyl)-5-(thiophen-3-yl)dihydrofuran-
2(3H)-one (2k) 
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1
H NMR (400 MHz, CDCl3) of compound 5-(azidomethyl)-5-(2,5-
dimethylphenyl)dihydrofuran-2(3H)-one (2l) 
 
 
13
C NMR (101 MHz, CDCl3) of compound -(azidomethyl)-5-(2,5-
dimethylphenyl)dihydrofuran-2(3H)-one (2l) 
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IR of compound -(azidomethyl)-5-(2,5-dimethylphenyl)dihydrofuran-2(3H)-one (2l) 
  
1
H NMR (400 MHz, CDCl3) of compound 8b-(azidomethyl)-3,3a,4,8b-tetrahydro-2H-
indeno[1,2-b]furan-2-one (2m) 
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13
C NMR (101 MHz, CDCl3) of compound 8b-(azidomethyl)-3,3a,4,8b-tetrahydro-2H-
indeno[1,2-b]furan-2-one (2m) 
 
IR of compound 8b-(azidomethyl)-3,3a,4,8b-tetrahydro-2H-indeno[1,2-b]furan-2-one (2m) 
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1
H NMR (400 MHz, CDCl3) of compound 5-(azidomethyl)-5-(phenylethynyl)dihydrofuran-
2(3H)-one (2n) 
 
 
13
C NMR (101 MHz, CDCl3) of compound 5-(azidomethyl)-5-(phenylethynyl)dihydrofuran-
2(3H)-one (2n) 
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1
H NMR (400 MHz, CDCl3) of compound 6-(azidomethyl)-6-phenyltetrahydro-2H-pyran-2-
one (2o) 
 
13
C NMR (101 MHz, CDCl3) of compound 5-(azidomethyl)-5-(phenylethynyl)dihydrofuran-
2(3H)-one (2n) 
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1
H NMR (400 MHz, CDCl3) of compound 6-(azidomethyl)-4,4-dimethyl-6-phenyltetrahydro-
2H-pyran-2-one (2p) 
 
13
C NMR (101 MHz, CDCl3) of compound 6-(azidomethyl)-4,4-dimethyl-6-phenyltetrahydro-
2H-pyran-2-one (2p) 
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1
H NMR (400 MHz, CDCl3) of compound 6-(azidomethyl)-6-phenyl-1,4-dioxan-2-one (2q) 
 
 
13
C NMR (101 MHz, CDCl3) of compound 6-(azidomethyl)-6-phenyl-1,4-dioxan-2-one (2q) 
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IR of compound 6-(azidomethyl)-6-phenyl-1,4-dioxan-2-one (2q) 
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 Spectra of new compounds for Lewis acid catalyzed aryl migration c.
1
H-NMR (400 MHz, CDCl3) of compound 5-azido-5-benzyldihydrofuran-2(3H)-one (4a)
 
  
13
C NMR (101 MHz, CDCl3) of compound 5-azido-5-benzyldihydrofuran-2(3H)-one  (4a)
 
IR of compound 5-azido-5-benzyldihydrofuran-2(3H)-one  (4a) 
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1
H NMR (400 MHz, CDCl3) of compound 5-azido-5-(4-bromobenzyl)dihydrofuran-2(3H)-
one (4b) 
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13
C NMR (101 MHz, CDCl3) of compound 5-azido-5-(4-bromobenzyl)dihydrofuran-2(3H)-
one (4b) 
 
 
IR of compound 5-azido-5-(4-bromobenzyl)dihydrofuran-2(3H)-one (4b) 
 
S77 
 
 
1
H NMR (400 MHz, CDCl3) of compound 5-azido-5-(4-fluorobenzyl)dihydrofuran-2(3H)-one 
(4c) 
 
13
C NMR (101 MHz, CDCl3) of compound 5-azido-5-(4-fluorobenzyl)dihydrofuran-2(3H)-
one (4c) 
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19
F NMR (376 MHz, CDCl3) of compound 5-azido-5-(4-fluorobenzyl)dihydrofuran-2(3H)-one 
(4c) 
 
 
 
 
IR of compound 5-azido-5-(4-fluorobenzyl)dihydrofuran-2(3H)-one (4c)  
 
S79 
 
 
1
H NMR (400 MHz, CDCl3) of compound 5-azido-5-(4-chlorobenzyl)dihydrofuran-2(3H)-one 
(4d) 
 
13
C NMR (101 MHz, CDCl3) of compound 5-azido-5-(4-chlorobenzyl)dihydrofuran-2(3H)-
one (4d)  
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IR of compound 5-azido-5-(4-chlorobenzyl)dihydrofuran-2(3H)-one (4d) 
 
1
H NMR (400 MHz, CDCl3) of compound 5-azido-5-(4-methylbenzyl)dihydrofuran-2(3H)-
one (4e) 
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13
C NMR (101 MHz, CDCl3) of compound 5-azido-5-(4-methylbenzyl)dihydrofuran-2(3H)-
one (4e) 
 
IR of compound 5-azido-5-(4-methylbenzyl)dihydrofuran-2(3H)-one (4e)  
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1
H NMR (400 MHz, CDCl3) of compound 5-azido-5-(2,5-dimethylbenzyl)dihydrofuran-
2(3H)-one (4f)  
 
1
H NMR (400 MHz, CDCl3) of compound 2-(2-iodophenyl)propan-2-ol 
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13
C NMR (101 MHz, CDCl3) of compound 5-azido-5-(2,5-dimethylbenzyl)dihydrofuran-
2(3H)-one (4f)  
 
13
C NMR (101 MHz, CDCl3) of compound 2-(2-iodophenyl)propan-2-ol 
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1
H-NMR (400 MHz, CDCl3) of compound 5-azido-5-(thiophen-3-ylmethyl)dihydrofuran-
2(3H)-one  (4g) 
 
13
C-NMR (101 MHz, CDCl3) of compound 5-azido-5-(thiophen-3-ylmethyl)dihydrofuran-
2(3H)-one (4g)
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IR of compound 5-azido-5-(thiophen-3-ylmethyl)dihydrofuran-2(3H)-one (4g) 
 
1
H NMR (400 MHz, CDCl3) of compound 5-azido-5-benzyl-3,3-dimethyldihydrofuran-2(3H)-
one (4h) 
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13
C NMR (101 MHz, CDCl3) of compound 5-azido-5-benzyl-3,3-dimethyldihydrofuran-
2(3H)-one (4h) 
 
IR of compound 5-azido-5-benzyl-3,3-dimethyldihydrofuran-2(3H)-one (4h) 
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1
H-NMR (400 MHz, CDCl3) of compound  3-azido-3-benzylisobenzofuran-1(3H)-one (4i) 
  
13
C-NMR (101 MHz, CDCl3) of compound 3-azido-3-benzylisobenzofuran-1(3H)-one (4i) 
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1
H-NMR (400 MHz, CDCl3) of compound 3-azido-3-(4-chlorobenzyl)isobenzofuran-1(3H)-
one (4j) 
 
13
C-NMR (101 MHz, CDCl3) of compound 3-azido-3-(4-chlorobenzyl)isobenzofuran-1(3H)-
one (4j) 
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IR of compound 3-azido-3-(4-chlorobenzyl)isobenzofuran-1(3H)-one  (4j) 
 
1
H-NMR (400 MHz, CDCl3) of compound  3-azido-3-(4-fluorobenzyl)isobenzofuran-1(3H)-
one  
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13
C-NMR (101 MHz, CDCl3) of compound 3-azido-3-(4-fluorobenzyl)isobenzofuran-1(3H)-
one  
 
19
F NMR (376 MHz, CDCl3) of compound 3-azido-3-(4-fluorobenzyl)isobenzofuran-1(3H)-
one  
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 spectra of new compounds from the Pd catalysis. d.
1
H-NMR (400 MHz, CDCl3) of compound 5-(azidomethyl)-5-(3-phenylpropyl)dihydrofuran-
2(3H)-one (2s) 
 
13
C-NMR (101 MHz, CDCl3) of compound 5-(azidomethyl)-5-(3-phenylpropyl)dihydrofuran-
2(3H)-one (2s) 
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IR of compound 5-(azidomethyl)-5-(3-phenylpropyl)dihydrofuran-2(3H)-one (s) 
 
1
H NMR (400 MHz, CDCl3) of compound 3-(azidomethyl)-3-methylisobenzofuran-1(3H)-one 
(2g) 
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13
C NMR (101 MHz, CDCl3) of compound 3-(azidomethyl)-3-methylisobenzofuran-1(3H)-
one (2g) 
 
 
 
IR of compound 3-(azidomethyl)-3-methylisobenzofuran-1(3H)-one (2g) 
 
S94 
 
1
H-NMR (400 MHz, CDCl3) of compound 3-(azidomethyl)isochroman-1-one (2t) 
 
 
13
C-NMR (101 MHz, CDCl3) of compound 3-(azidomethyl)isochroman-1-one (2t)
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IR of compound 3-(azidomethyl)isochroman-1-one (2t) 
 
1
H-NMR (400 MHz, CDCl3) of compound 3-(Azidomethyl)-3-methylisochroman-1-one (2u) 
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13
C-NMR (101 MHz, CDCl3) of compound 3-(Azidomethyl)-3-methylisochroman-1-one (2u) 
 
 
IR of compound 3-(Azidomethyl)-3-methylisochroman-1-one (2u) 
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1
H-NMR (400 MHz, CDCl3) of compound 3-(Azidomethyl)-3-
((benzyloxy)methyl)isochroman-1-one (2v)  
 
13
C-NMR (101 MHz, CDCl3) of compound 3-(Azidomethyl)-3-
((benzyloxy)methyl)isochroman-1-one (2v) 
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IR of compound 3-(Azidomethyl)-3-((benzyloxy)methyl)isochroman-1-one (XX) 
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 Spectra of new compounds from derivatization. e.
 
1
H-NMR (400 MHz, CDCl3) of compound 4-oxo-5-phenylpentanoic acid (6) 
 
 
13
C-NMR (101 MHz, CDCl3) of compound 4-oxo-5-phenylpentanoic acid (6)  
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1
H-NMR (400 MHz, CDCl3) of compound methyl 4-oxo-5-phenylpentanoate (7) 
 
 
 
13
C-NMR (101 MHz, CDCl3) of compound methyl 4-oxo-5-phenylpentanoate (7)
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1
H-NMR (400 MHz, CDCl3) of compound 3-(4-fluorobenzyl)-3-(4-phenyl-1H-1,2,3-triazol-1-
yl)isobenzofuran-1(3H)-one (8) 
 
13
C-NMR (101 MHz, CDCl3) of compound 3-(4-fluorobenzyl)-3-(4-phenyl-1H-1,2,3-triazol-1-
yl)isobenzofuran-1(3H)-one (8)
 
S102 
 
 
19
F NMR (376 MHz, CDCl3) of compound  3-(4-fluorobenzyl)-3-(4-phenyl-1H-1,2,3-triazol-
1-yl)isobenzofuran-1(3H)-one (8) 
 
IR of compound 3-(4-fluorobenzyl)-3-(4-phenyl-1H-1,2,3-triazol-1-yl)isobenzofuran-1(3H)-
one (8) 
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1
H-NMR (400 MHz, CDCl3) of compound 4-((tert-butoxycarbonyl)amino)-5-(4-
chlorophenyl)pentanoic acid (9) 
 
13
C-NMR (101 MHz, CDCl3) of compound 4-((tert-butoxycarbonyl)amino)-5-(4-
chlorophenyl)pentanoic acid (9)  
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HSQC of compound 4-((tert-butoxycarbonyl)amino)-5-(4-chlorophenyl)pentanoic acid (9) 
  
 
 
IR of compound 4-((tert-butoxycarbonyl)amino)-5-(4-chlorophenyl)pentanoic acid (9) 
 
S105 
 
1
H-NMR (400 MHz, CDCl3) of compound 3-amino-3-(4-fluorobenzyl)isobenzofuran-1(3H)-
one (10) 
 
13
C-NMR (101 MHz, CDCl3) of compound 3-amino-3-(4-fluorobenzyl)isobenzofuran-1(3H)-
one (10) 
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19
F NMR (376 MHz, CDCl3) of compound 3-amino-3-(4-fluorobenzyl)isobenzofuran-1(3H)-
one (10) 
 
IR of compound -amino-3-(4-fluorobenzyl)isobenzofuran-1(3H)-one (10) 
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